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ABSTRACT
Breast cancer is the commonest type of malignancy in the United Arab Emirates
(UAE) with more than 65% of women diagnosed at an advanced stage. Routine
clinical screening has aided in the early detection of breast cancer. However, more
than 71% of breast tumors are self-detected. Therefore, exploring factors
influencing delayed presentation to treatment after self-detection of breast tumors
by Emirati and Arab women in the UAE is essential for improving the survival
and the development of effective and targeted health intervention programs. This
project explores the reasons behind delayed presentation to treatment by
symptomatic women. It uses several approaches, including the development of a
multidimensional model of help-seeking grounded in data from in-depth
interviews with late presenters and nested in the theory of illness behavior. The
study shows that despite continued emphasis on screening for breast cancer, delay
is still prevalent amongst women. In the UAE, there is therefore a need for
continued emphasis on the message regarding early detection for breast cancer
symptoms. The results include the significant influence of social and cultural
factors and life expectations on women with breast cancer. The suitability of the
national breast cancer screening guidelines was reviewed through a 5- year
survival analysis of breast cancer cases. The results show the importance of
cultural and psychosocial beliefs in women’s decision to seek medical attention.
Delays of more than 3 months were highly associated with a decrease in survival
time (pvalue=0.039), although lead-time bias could well be a possible
explanation. The relatively younger age at diagnosis in Arab women compared to
Western women indicates a need to start clinical screening at younger ages. The
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establishment of a national cancer registry could help in the generation of accurate
data to determine trends and for comparison with other countries in the region.
The delayed presentation model can also serve as a reference for future studies on
health behaviors modification and health promotion initiatives.

Keywords: Breast cancer, delayed presentation, qualitative methods.
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الملخص
سرطان الثدي من أكثر السرطانات شيوعا في دولة االمارات العربية المتحدة (ا ع م) مع وجود
اكثر من  %56امرأة في مراحل متقدمة من السرطان .االبكار من التشخيص و العالج يحسن من فرص
العالج و النقاهة .الفحص الدوري الكلينيكي يساعد على الكشف المبكرلسرطان الثدي .ولكن أكثر من %17
من حالت سرطان الثدي تكتشف ذاتيا .ولذلك البحث عن األسباب التي تؤدي الى التأخر في طلب العالج
لدى النساء االماراتيات و العربيات الالتي اكتشفن سرطان الثدي ذاتيا مهم جدا للحد من الوفيات و لتصميم
برامج صحية و توعوية هادفة و عملية .هذا المشروع يبحث عن األسباب المؤدية للتأخر في طلب العالج
من قبل النساء الالتي يكتشفن سرطان الثدي ذاتيا مستخدما عدة طرق منها بناء نظرية متعددة األوجه
واستخدام نظرية الفعل المرضي من خالل مقابالت فردية متعمقة مع نساء مصابات بحالة متقدمة من
سرطان الثدي بعد التأخر في طلب العالج .نحن نقدم تحليل يبين ان االحساس البدني و الشعور بأعراض
المرض مقنن في التفاعل بين عدة عوامل اجتماعية و السيرة الذاتية مع التوقعات الحياتية وتوافقها مع قيم
العقيدة و المجتمع .التعرف على أعراض المرض من المشاكل الصحية العامة في دولة االمارات .التوعية
المستمرة بسرطان الثدي و أعراضه و الكشف المبكر بالنسبة للنساء و أقاربهم و الرعية الصحية األولية و
العاملين بها مهم جدا .الدعم المستمر للنساء المصابات بسرطان الثدي مهم جدا .باالضافة لذلك ,مناسبة
معايير الفحص الدوري لسرطان الثدي في دولة االمارات تمت مراجعتها باستخدام بيانات البقاء على قيد
الحياة لخمس سنوات .النتائج تبين أهمية العوامل االجتماعية و النفسية المؤثرة في اتخاذ القرار للبحث عن
المساعدة الصحية .التأخر في البحث عن العالج كان من أقوى المؤثرات السلبية على البقاء على قيد الحياة.
مع أن التحيز للمهلة يمكن أن يكون سبب قوة المؤثر .صغر سن النساء المصابات بسرطان الثدي في دولة
االمارات مقارنة بالنساع في دول الغرب يؤيد أهمية تطبيق الفحص الدوري للكشف المبكر في سن مبكرة.
تأسيس سجل للسرطانات سيمكن من وجود معلومات مكتملة وواضحة للمقارنة في المستقبل مع دول
مجاورة .النظرية المبنية من هذا البحث يمكن أن تستخدم كمرجع لفهم السلوكيات المرضية و لتصميم برامج
توعوية في المستقبل.

الكلمات المفتاحية :سرطان الثدي ,التأخر في التقدم للعالج ,الطرق النوعية
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Chapter one
INTRODUCTION

Breast cancer is the most common form cancer among women worldwide.
The most recent estimate by Forouzanfar et al. (2010) indicates that more than 1.6
million new cases of breast cancer occurred among women worldwide in 2010.
The number of breast cancer cases has been steadily increasing. Global breast
cancer incidence increased from 641, 000 cases in 1980 to 1, 643, 000 cases in
2010, an annual rate of increase of 3.1% and a cumulative incidence increase of
more than 25% between 1980 and 2010. The increase of another known
reproductive health problem for women, cervical cancer, is less pronounced,
increasing from 378, 000 cases to 454, 000 during the same period, an average
annual increase of 0.6%. The global total number of deaths per year from breast
cancer has increased from 250, 000 in 1980 to 425, 000 an annual rate of increase
of 1.8%, compared to the lower annual rate of increase of 0.46% for cervical
cancer (Forouzanfar et al., 2010).
Control of modifiable breast cancer risk factors such as maintaining a
healthy weight, regular exercise and reducing alcohol intake could eventually
have an impact in reducing the incidence of breast cancer. However, these
strategies cannot eliminate the majority of breast cancers. Therefore, early
detection in order to improve breast cancer outcome and survival remains the
cornerstone of breast cancer control (Anderson & Jakesz, 2008). Early detection
involves the use of two methods: (1) first, improving and increasing the awareness
of breast cancer risk factors and signs and symptoms in symptomatic populations
in order to facilitate early detection and early treatment, and (2) second, the
adoption of screening tests in a presumably asymptomatic population to detect the
disease in its early stages. For breast cancer screening programs to be effective,
regular and periodic participation of women is needed.
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The lack of participation of women in breast cancer screening programs
and delays in seeking medical attention when symptoms appear might be
attributable to economic and healthcare access issues (Alkhasawneh, 2007;
Hatefnia et al., 2010; Lamyian et al., 2007; Seif & Aziz, 2000). In the Arab world,
culture and religion play a major role in facilitating or hindering screening and
early detection of breast cancer (Azaiza & Cohen, 2008; Hatefnia et al., 2010;
Baron-Epel, 2010). The social and the religious role that women play in the Arab
community and the social stigma around breast cancer may have prevented the
early detection of the disease. Many factors play a role in creating cancer
disparities. Some of these factors are socio-economic status, culture, and social
injustice, with poverty being the dominant factor (Freeman, 2004). The American
Cancer Society (2008) reports that “Complex and interrelated factors contribute to
the observed disparities in cancer incidence and death among racial, ethnic, and
underserved groups. The most obvious factors are associated with a lack of health
care coverage and low socioeconomic status”. The goal of many researchers
investigating disparities in cancer between communities is to improve rates of
cancer screening and better cancer outcomes by increasing the medical
community’s understanding of this complex interplay of socio-cultural and
religious factors in cancer outcomes.
Significance of study
In the UAE, breast cancer is the commonest type of malignancy. It is at
the top of the list of the leading types of cancer (Tawam Cancer Registry, 2012).
Breast cancer is therefore a growing public health issue in the UAE. Despite the
inaccurate estimation of breast cancer burden in the UAE due to under-reporting
of breast cancer cases and the lack of a national cancer registry and death registry
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to confirm the occurrence and mortality of cases, the cumulative probability of
breast cancer incidence in the UAE increased over the past three decades, being
2% in 1980, 2.4% in 1990, 3.9% in 2000 and 5.2% in 2010 (Forouzanfar et al.,
2010). This rising incidence is the not only cause for concern in the UAE, but also
the advanced stage at presentation (Sabih et al., 2012). In women of all
nationalities in the UAE, between 2005 and 2007, more than 65% presented at a
late stages of the disease (either with regional or metastatic disease) at first
diagnosis (Taher et al., 2008).
There is evidence that women with relevant symptoms who wait
more than three months before seeking medical advice have significantly
lower survival rates than women who seek early medical attention
(Ramirez et al., 1999). Common underlying causes related to patient delay
are lower education (Arndt et al., 2003), lower socioeconomic status
(Harirchi et al., 2005), and an apparent lack of concern regarding painless
breast lumps (Piñeros et al., 2009). In the Gulf region, it has been
commonly assumed that late diagnosis is due to the lack of knowledge
about breast cancer, cultural beliefs and deficient coverage of screening
programs (Lodhi et al., 2010). However, there is scant research in GCC
countries regarding reasons for delayed presentation of female breast
cancer.
The breast cancer situation in the UAE
The United Arab Emirates is a federation of seven emirates
situated in the southeast of the Arabian Peninsula in Southwest Asia on the
Arabian Gulf. The country has land borders with Oman and Saudi Arabia
and shares sea borders with Iraq, Kuwait, Bahrain, Qatar and Iran. Of the
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total 6 million residents, less than 20% are Emirati and more than half are South
Asian. The religious background of UAE residents includes Muslim, Hindus and
Christians (Taher et al., 2008).
UAE health standards are rising rapidly and citizens and residents have
taken advantage of healthcare facilities throughout the country. The health system
in the country is administered by three authorities, (1) Abu Dhabi Health
Authority (HAAD), which is responsible for the healthcare sector in the capital
and emirate of Abu Dhabi; (2) the Dubai Health Authority which runs the
healthcare sector in the commercial emirate of Dubai; (3) the Ministry of Health
which oversees the entire healthcare delivery systems in the United Arab
Emirates, but mainly the remaining five emirates (Sharjah, Ajman, Ras
Alkhaimah, Fujairah, Umm AlQwain). In 2007, a health insurance system started
in the emirate of Abu Dhabi and all residents are now required to be insured as a
part of obtaining a residency visa in the UAE. In the emirate of Dubai, health
insurance is not yet mandatory, however it will be part of obtaining a residency
visa by 2014. In the other five emirates, the Ministry of Health issues health cards
to all citizens which covers the cost of most emergency and chronic health
conditions.
Cancer moved from the third leading cause of death in the UAE to be the
second leading cause of death after cardiovascular diseases (HAAD, 2010).
Cancer caused 13.9% of all reported deaths in the emirate of Abu Dhabi in 2009
(HAAD, 2010). Breast cancer is the most common diagnosed cancer among
females in Abu Dhabi. The exact number of cancer patients in the whole of the
UAE is difficult to determine. There is no centralized cancer registry system in the
UAE, and data often only becomes available after patients are admitted to
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hospitals in advanced stages of the disease. A number of patients seek
diagnosis and treatment overseas and their cases may not be registered
with UAE hospitals or local health authorities.
The health system in the emirate of Abu Dhabi
The population of the emirate of Abu Dhabi has grown rapidly in
recent years. One in five residents is national citizens of whom two thirds
are under 30 years old and half under 19 (Taher et al., 2008). The
introduction of mandatory health insurance in 2007 in the emirate of Abu
Dhabi has provided all residents access to high quality care (Taher et al.,
2008). Late detection of breast cancer has historically led to significant
increases in mortality rates. Female adult nationals between 40 and 69 are
being given an option for breast cancer screening as part of their insurance
card renewal process. For expatriates, screening campaigns have helped in
early detection of breast cancer, however, screening is not performed on
an organized basis and some insurance companies do not cover screening
cost (Taher et al., 2008). Some preventive medicine centers provide free
screening, but its availability is not widely publicized.
Statistics
Data from the Tawam Hospital cancer registry are limited.
However, current available data shows that breast cancer is the
commonest cancer in women in UAE (Taher et al., 2008). It is the second
leading cause of death among women and accounts for 28% of all female
deaths. Every year there are more than 130 new cases of breast cancer
diagnosed in the emirate of Abu Dhabi. 87% of breast cancer cases occur
after the age of 40 years. More than 65% of women with breast cancer,
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regardless of nationality, present at late stages of the disease (either with regional
or metastatic disease) at first diagnosis (Figure 1), compared with approximately
15% in the USA (Taher et al., 2008).

Figure 1: Stage of breast cancer at diagnosis by nationality, Abu Dhabi 2005-2007
(Tawam hospital cancer registry, 2009)

The mortality rate for breast cancer is 44%, compared with 10‐15% for the
USA. This is likely to be because of late presentation at first diagnosis and due to
the larger proportion of the younger women in the population of the UAE. Breast
cancer affecting younger women tends to be more aggressive (Swanson & Lin,
1994). In the emirate of Abu Dhabi, the estimated total number of females was
672,512 in mid-2012 and 64% of them were over the age of 20. 66% are nonnationals. The total number of women aged 40-69 years was 113,633 (16.9% of all
females). Figure (2) illustrates female breast cancer incidence rates by nationality
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and gender in 2012. The incidence rate is higher in UAE nationals as compared to
non-nationals.

Figure 2: Female breast cancer cases by nationality and gender in 2012 (Tawam
hospital cancer registry, 2012)

Survival and prognosis
Early diagnosis and treatment of breast cancer improves prognosis.
Detection of cancer in its preclinical stage requires routine screening of
asymptomatic women (Tabar et al., 2005). Improving survival and
preventing death is the goal of healthcare professionals when dealing with
breast disease. The prognosis for diagnosing breast cancer at a later stage
has been poor regardless of therapy given and death within that period of
diagnosis is usually the outcome. Women with mammographically
detected non-palpable breast lump localized to the breast will have a
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favorable chance of survival compared to women who self-discover a palpable
larger breast lump which has a higher chance of spread beyond the breast tissue
(Tabar et al., 2011). See figure (3).

Figure 3: 20+ year outcome of patients with 1-9mm and 10-14mm breast cancer
(Tabar et al., 2011)

According to the National Cancer Institute (2012), several types of
statistics may be used to estimate a cancer patient’s prognosis. The most
commonly used statistics are listed below.


Cancer-specific survival: This statistic calculates the percentage of patients
with a specific type and stage of cancer who have survived that is, not died
from their cancer during a certain period of time (1 year, 2 years, 5 years,
etc.) after diagnosis. Cancer-specific survival is also called diseasespecific survival. In most cases, cancer-specific survival is based on causes
of death in medical records, which may not be accurate. To avoid this
inaccuracy, another method used to estimate cancer-specific survival that
does not rely on information about the cause of death is relative survival.
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Relative survival: This statistic compares the survival of patients
diagnosed with cancer (e.g., breast cancer) with the survival of people in
the general population who are of the same age, race, and sex and who
have not been diagnosed with that cancer. It is thus the percentage of
cancer patients who have survived for a certain period of time after
diagnosis relative to people without cancer.



Overall survival: This statistic is the percentage of patients with a specific
type and stage of cancer who are still alive, that is, have not died from any
cause during a certain period of time after initial diagnosis.



Disease-free survival: This statistic is the percentage of patients who have
no evidence of cancer during a certain period of time after treatment. Other
similar terms are recurrence-free or progression-free survival.

Prognostic factors/ predictors
“A prognostic factor is capable of providing information on
clinical outcome at the time of diagnosis, independent of therapy”. These
markers are usually indicators of growth, invasion, and metastatic
potential (Foukakis & Bergh, 2013). During the past few decades, there
has been major improvements in the management of breast cancer.
Identification of prognostic factors helps in the management of the disease
(Singletary, 1999). Prognostic factors include tumor size, lymph nodes,
histologic grade, stage, estrogen and progesterone receptors and
HER2/neu (erB-2) oncogene alteration (Rubin & Reisner, 2009).
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Tumor size
Early detection of non-palpable breast lumps or smaller size lumps
improves the prognosis. Figure (4) shows the effect of tumor size upon discovery
on long term survival (Tabar et al., 2005).

Figure 4: Cumulative survival of breast cancer patients aged 40-74 (Tabar et al.,
2011)

The shape of the tumor (differentiation/see definition of terms) is also
considered a prognostic factor; tumors with indistinct margins (poor
differentiation) tend to be more aggressive (Rubin & Reisner, 2009).
Node status
Breast cancer spreads regionally by direct extension (e.g., to the chest
wall) or through the lymphatic channels to the axillary or supraclavicular lymph
nodes (Rubin & Reisner, 2009). Metastasis to the axillary lymph nodes and the
number of lymph nodes involved is the single most important prognostic factor
for breast cancer (Masood, 1997). When axillary lymph nodes are negative for
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metastasis, the 10 year disease free survival rate is improved. With each
positive lymph node the survival declines (Masood, 1997). If the cancer is
ductal carcinoma in situ (DCIS) “the presence of malignant epithelial cells
that have not penetrated the basal membrane” (Rubin & Reisner, 2009, p.
428) or has not spread to the lymph nodes (node negative), the 5-year
survival rates with treatment can reach 98%. If the cancer has spread to the
lymph nodes or beyond the primary tumor site (node positive), the 5-year
survival rate is approximately 84%. If the cancer has spread (metastasized)
to other sites (most often the lung, liver, and bone), the average 5-year
survival rate is 23% (National Breast Cancer Foundation, 2010).
Histologic grade
Tumor grade is a description of how abnormal the tumor cells and
the tumor tissue appear under the microscope. If the cells of the tumor are
close to the normal tissue structure, the tumor is termed well
differentiated. These tumors tend to grow and spread at a slower rate than
tumors that are “undifferentiated” or “poorly differentiated,” which have
abnormal looking cells and may lack normal tissue structures. Breast
tumors progress gradually to higher grades with time. Early detection aids
in detecting smaller tumors at lower histological grades (Tabar et al.,
2005). Tumors are graded as 1, 2, 3, or 4, depending on the amount of
abnormality. The American Joint Committee on Cancer (AJCC) classified
the tumor grade as following:
GX: Grade cannot be assessed (undetermined grade)
G1: Well differentiated (low grade)
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G2: Moderately differentiated (intermediate grade)
G3: Poorly differentiated (high grade)
G4: Undifferentiated (high grade)
In Grade 1 tumors, the tumor cells and the organization of the tumor tissue
appear close to normal. These tumors tend to grow and spread slowly. In contrast,
the cells and tissue of Grade 3 and Grade 4 tumors do not resemble normal cells
and tissue. Grade 3 and Grade 4 tumors tend to grow rapidly and spread faster
than tumors with a lower grade.
Staging
Breast cancer is characterized using the Tumor, Node, Metastases system
(TNM), see table (1). The AJCC, provides cancer classification to aid in the
process of assessing prognosis and assigning treatment protocol. The
classification involves three criteria, Primary tumor (T), Regional lymph nodes
(N), and distant metastasis (M).
Primary tumor (T)
T stands for the primary tumor and the primary tumor is classified as
follows:
T1: Tumor 2.0 cm or less in greatest dimension
T1mic: Micro-invasion 0.1 cm or less in greatest dimension
T1a: Tumor more than 0.1 but not more than 0.5 cm in greatest dimension
T1b: Tumor more than 0.5 cm but not more than 1.0 cm in greatest dimension
T1c: Tumor more than 1.0 cm but not more than 2.0 cm in greatest dimension
T2: Tumor more than 2.0 cm but not more than 5.0 cm in greatest dimension
T3: Tumor more than 5.0 cm in greatest dimension

13

T4: Tumor of any size with direct extension to (a) chest wall or (b) skin,
T4a: Extension to chest wall
T4b: Edema (including peaud'orange) or ulceration of the skin of the
T4c: Both of the above (T4a and T4b)
T4d: Inflammatory carcinoma
Regional lymph nodes
N describes the axillary lymph nodes involvement. It is
documented as follows:
NX: Regional lymph nodes cannot be assessed (e.g., previously removed)
N0: No regional lymph node metastasis
N1: Metastasis to movable ipsilateral axillary lymph node(s)
N2: Metastasis to ipsilateral axillary lymph node(s) fixed to each other or to other
structures N3: Metastasis to ipsilateral internal mammary lymph node(s)
Distant metastasis (M)
Distant metastasis describes the status whereby the cancer has
moved out of the breast to body organs other than the regional lymph
nodes.
MX: Presence of distant metastasis cannot be assessed.
M0: No distant metastasis
M1: Distant metastasis present (includes metastasis to ipsilateral supraclavicular
lymph nodes) see table (1).
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Table 1: Breast cancer staging according to TNM grouping, (AJCC)
The frequency of advanced breast cancer in a population is a strong
predictor for the mortality rate in the same population. The five-year survival rate
can be calculated. Based on the prognostic factors the survival rate increases or
decreases. (See table 2).
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Stage

Five years relative
survival rate

0

100%

I

100%

IIA

92%

IIB

81%

IIIA

67%

IIIB

54%

IV

20%

Table 2: Stages and survival of breast cancer (American Cancer Society, 2010)

Estrogen and progesterone receptors status
The hormones estrogen and progesterone can bind or connect to
breast cancer cells if they contain receptors, or binding sites. Cells
containing these binding sites are known as hormone receptor-positive
cells. Women whose cancers express hormone receptors are typically
older and have low grade tumors and a better prognosis (Rubin & Reisner,
2009). Approximately 75% of breast cancers are estrogen receptorpositive (ER-positive, or ER+). Approximately 65% of ER-positive breast
cancers are also progesterone receptor-positive (PR-positive, or PR+)
(Jatoi et al., 2007). Cells that have receptors for one of these hormones, or
both of them, are considered hormone receptor-positive. The presence of
these receptors indicates a greater probability of response to hormonal
therapy (Rubin & Reisner, 2009).
Human Epidermal Growth Factor Receptor 2 (HER2)
“This is a protein involved in normal cell growth. It is found on
some types of cancer cells, including breast and ovarian. Cancer cells
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removed from the body may be tested for the presence of HER2/neu to help
decide the best type of treatment” (National Cancer Institute, 2012).
Approximately 25% of breast cancers, the HER2 gene does not work correctly. In
response, breast cells increase the HER2 receptors. This makes breast cells grow
and divide in an uncontrolled way. Over expression of HER2/neo is identified in
between 10% and 35% of primary breast tumors and is mostly attributable to gene
amplification. A monoclonal drug (Herceptin/trastuzumab) has been shown to
benefit patients with HER2/neo gene amplification. Herceptin attaches to the
HER2 receptors on breast cancer cells and blocks them from receiving growth
signals (Rubin & Reisner, 2009). In this way, the growth of breast cancer is
controlled.
Early detection
Awareness and education
Increasing awareness and education are effective ways for early detection
of breast cancer. Simple and popular means of education include television
advertisements, radio and newspaper campaigns. The highest benefits of
educational programs can be achieved through well designed culturally sensitive
programs. Education should also target men, as men could be a positive influence
for women in regards to participation in screening programs (Smith et al., 2006).
In the UK, Stockton et al (1997) reported a dramatic increase in the early
detection of breast cancer in the 1980s after the launch of an education and
awareness program.
In the UAE, information on breast health varies between different
healthcare providers (Taher et al., 2008). Education activities are especially active
during October because it is assigned internationally as the breast cancer
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awareness month, and screening is widely offered, leading to sharp
increases in mammography uptake during October and dropping to lower
levels for the rest of the year. At this time community outreach programs
are insufficient and screening is opportunistic rather than regular.
Healthcare professionals have a major role to play in improving awareness
and early detection as they have regular contact with women in the
community (Yarbo, 2003). Unfortunately, UAE healthcare professionals
often lack awareness of screening guidelines and the availability of
existing screening programs (Taher et al., 2008).
Breast cancer screening is a way for reducing morbidity and
mortality and improving the survival rate (Anderson et al., 2003).
Mammography has been widely used and accepted as a mean for early
detection of breast cancer and its use has been linked to early diagnosis of
the disease and reduced mortality (Stockton et al., 1997). A two country
Swedish trial (Tabar et al., 2011) has the longest follow up of any breast
screening trial to date, with a maximum of 29 years follow up for cancer
mortality. This trial reported 30% mortality reduction from invitation to
screening. Table 3 shows the absolute numbers of deaths prevented and
the estimated numbers of women needed to be screened during the 7 years
of screening to save one life (Tabar et al., 2011). This in turn would mean
that for 1,000 women screened every 2 years from ages 40 through 69
years, between 8 and 11 breast cancer deaths would be prevented. In the
UK National Breast Screening Program, for every 1,000 women attending
three yearly screenings from ages 47 to 73 years (nine screening episodes),
five to seven breast cancer deaths would be prevented. (See table 3)
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Table 3: The absolute numbers of deaths prevented and the estimated numbers of
women needed to screen during the 7 years of screening to save one life (Tabar et
al., 2011)

At a national level, the UAE Ministry of Health is the key provider of
breast cancer screening programs, which began in 1995. These programs follow
international recommendations which include a combination of monthly Breast
Self-Exam (BSE), regular Clinical Breast Exam (CBE) and a mammography
every two years after the age of forty (Sadler et al., 2001a; Pearlman et al., 1999).
UAE society has experienced major shifts in lifestyle over the past five decades
because of acquired oil wealth (Bener et al., 2001). Screening services are widely
available and free of charge for national women over the age of forty. Despite
this, the participation of women in screening activities is very low (10%) (Taher,
et al., 2008). The overall goal of the program is to achieve a70% participation
rate by 2013 (Taher et al., 2008). Many barriers to breast cancer screening and
underutilization of services have been studied worldwide, but in the UAE very
few studies have been conducted.
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Screening
Screening patients for preclinical disease is an established part of day to
day medical practice. A screening test must detect cases in sufficient numbers and
at an acceptable cost, and it must not carry side effects that outweigh the benefits
of screening. As with all diagnostic tests, there is a tradeoff between sensitivity
and specificity, and the competing needs for each must be balanced. In addition to
its sensitivity and specificity, the performance of a test is measured by its
predictive value. The predictive value of a positive result is the probability that a
person who reacts positively to the test actually has the disease. The predictive
value varies with the prevalence of disease in the population to whom the test is
applied. If the prevalence is low then there are more false positive results than true
positives, and predictive value falls. At the extreme, if nobody has the disease
then the predictive value will be zero, all positive test results will be false
positives. It follows that a test that functions well in normal clinical practice will
not necessarily be useful for screening purposes.
Breast self-examination (BSE)
For BSE, the steps are similar to Clinical Breast Examination (CBE) with
the difference being that the woman will be performing it for herself. The optimal
time to do it is a few days after the cessation of the menstrual flow. It is
recommended that women start regular BSE by the age of 20, to be aware of her
breast anatomical and physiological features and to detect any. Optimal benefits
of BSE could be attained through effective and detailed step by step instructions
by healthcare professionals (Hindle, 1999). The National Breast Cancer
Foundation (2010) reported that 70% of breast cancers were discovered by
women performing regular BSE. Women’s recall of the method of breast cancer
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detection in a population based study in the USA found that the proportion of
breast cancers that were self-detected by women aged 20-44 years using BSE was
71.2% much higher than either the proportion of cancers detected using CBE
9.3% or the proportion identified by mammography (19.6%) (Coats et al., 2001).
In a survey of Arab women in the UAE, 12.7% women practiced regular BSE
(Bener et al., 2001). The 5 steps to perform BSE are:
1. Stand in front of a mirror that is large enough for you to see your
breasts clearly. Check each breast for anything unusual. Check the
skin for puckering, dimpling, or scaliness. Look for a discharge from
the nipples.
2. Watching closely in the mirror, clasp your hands behind your head
and press your hands forward.
3. Next, press your hands firmly on your hips and bend slightly toward
the mirror as you pull your shoulders and elbows forward.
4. Gently squeeze each nipple and look for a discharge.
5. The breasts are best examined while lying down because it spreads
the breast tissue evenly over the chest. Lie flat on your back, with one
arm over your head and a pillow or folded towel under the shoulder.
This position flattens the breast and makes it easier to check.
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Clinical breast examination (CBE)
The clinical breast examination is a diagnostic technique used by
healthcare professionals to examine the breasts which includes palpation of the
breast to detect the presence of abnormal masses, e.g., tumors. It is these similar
to BSE. The steps used are the same whether the examination is a routine annual
examination or a diagnostic examination following a breast complaint. The
procedure generally should be done in a relaxed and private atmosphere. Culture
and personal preference need to be considered and respected as most women
would prefer a female physician or nurse to perform the procedure (Hindle, 1999).
This is especially so in the conservative societies in the Middle East. The
sensitivity (refer to definitions) for CBE ranges from 40% to 70%, and specificity
(refer to definitions) ranges from 86% to 99% (Agency for Healthcare Research
and Quality, 2008). CBE and BSE are not primarily cancer prevention methods.
Several studies have demonstrated benefits from these techniques through the
detection of smaller lumps by women performing regular CBE and BSE (Hindle,
1999). During periodic health visits, CBE might play a particularly important role
in identifying cancers among the significant proportion of women who do not
adhere to mammography screening guidelines, but who see their primary care
provider on a regular basis (McDonald et al., 2004).
Screening mammography
The best documented technique for early breast cancer detection is a
combination of regular breast examination and mammography. Mammography
employs the use of imaging x-rays to see the breast tissues and detect
abnormalities. Mammography could be a screening or diagnostic test. There is
strong evidence in favor of mammography as the best technique to detect breast
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tumors that are not even palpable. It has been shown that mammography can
reduce mortality by up to 30% (Tabar et al., 2005) and in a recent study by 20%
(Independent UK Panel on Breast Cancer Screening, 2012). Studies showed that
sensitivity of mammography is approximately 90% for palpable breast tumors
(80%-85% for both palpable and nonpalpable breast tumors). Humphry et al.,
(2002) reported that for a 1-year screening interval, the sensitivity of first
mammography ranged from 71% to 96%. Sensitivity was substantially lower for
women in their 40s than for older women. Regarding the specificity and positive
predictive value (PPV/ refer to definitions), they reported that in the randomized
trials, the specificity of a single mammographic examination was 94% to 97%.
This indicates that 3% to 6% of women who did not have cancer underwent
further diagnostic evaluation, typically a clinical examination, more
mammographic views, or ultrasonography. The positive predictive value of onetime mammography ranged from 2% to 22% for abnormal results requiring
further evaluation and from 12% to 78% for abnormal results requiring biopsy. In
conclusion, mammography is less specific than sensitive, therefore further
confirmatory investigations are needed to confirm the diagnosis (Hindle, 1999).
The American Cancer Society (2010) recommends that regular routine
mammographic screening begin at age of 40. The same guidelines specify that
women between 40-49 years of age should undergo regular mammography at one
to two year intervals in combination with BSE and CBE.
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Chapter two
OBJECTIVES

Statement of the problem
A delay in the presentation to treatment after self-discovery of breast
cancer symptoms by women in the UAE results in poor prognosis and lower
survival rates.
General objective:
This study aims to describe the pattern of breast cancer presentation in the
UAE and to explore the factors influencing delayed presentation to treatment of
Emirati & Arab women. This study also intends to highlight areas within this field
which may be in need of assessment and improvement to improve standards and
quality of breast cancer screening and early detection programs.
Objectives:
1. Describe breast cancer presentation patterns in the UAE.
2. Assess breast health awareness among women at screening age (≥40 years
old) and to explore barriers to regular screening.
3. Explore factors influencing delayed presentation to treatment of Emirati
and Arab women in the UAE.
4. Examine the use of a health seeking model to predict and explain
facilitators and barriers to women’s health seeking behavior in a complex
society.
Benefits of the study
This study will not only contribute to the existing knowledge on this topic
but will also help suggest, develop and establish national health policies for early
detection of breast cancer.
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Hypothesis
The lack of awareness about breast cancer and cultural and
psychosocial beliefs play a major role in delayed presentation to treatment
and act as a barrier for screening and thus early detection. Understanding
the determinants of delayed presentation to treatment by women in the
UAE is important for the development of effective and targeted health
interventions.
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Chapter three
REVIEW OF THE LITERATURE

Methods of literature search
A literature review was conducted by using the Pubmed and Medline
databases. A manual search was also undertaken for relevant journals identified
by the electronic search and additional articles identified from the reference lists
of key articles. A number of articles were found on breast cancer knowledge,
attitude and practice in the Middle East but only one article in the UAE. No
literature was found regarding delayed presentation to treatment by women in the
UAE. The search strategy was based on the terms: breast cancer survival,
pattern/trend of presentation, Patient Delay, Early/Late/Delayed
Presentation/Diagnosis, Care/Help/Help seeking, early detection/screening,
attitude/practice/knowledge and Breast Cancer (MeSH terms applied). Around
350 eligible articles were identified and further filtered to 150 articles. To
eliminate search bias, another researcher adopted the same search procedure
independently. There was no discrepancy in regards to articles retrieved. See
figure (5).
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Figure 5: Flow diagram of literature search

Extent of the problem
Breast cancer in developing countries is characterized by late presentation,
advanced stage of disease at diagnosis, worse biologic behavior and occurrence in
younger women than reported in developed countries (Lodhi et al, 2010). Prior
studies have estimated that approximately one third of women experiencing
symptoms of breast cancer delay seeking help for at least 3 months, and
approximately 25% of women will delay 6 months or longer (Lannin et al, 1998;
Piñeros et al, 2009). Among poor or minority populations, the percent of women
who delay at least 3 months may be as high as 45% (Lodhi et al, 2010).
Alwan (2010) reported that although women self-detected breast lumps in
90.6% of cases in Iraq, only 32% sought medical advice within the first month.
These observations reflect the poor breast health education of women and the lack
of knowledge about breast cancer screening. The literature from developing
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countries suggests that the advanced disease at presentation is a reflection of the
cultural norms which downplay women’s health problems (Miller, 1989). It is
believed that the improved survival rates of breast cancer in the USA and Europe
are related to an earlier stage at presentation instead of improved treatment
(Etzioni et al., 2003).
Breast cancer pattern of presentation and survival
The age adjusted incidence rates (ASR) for breast cancer are increasing in
many Arab countries, e.g., Lebanon (from 20 in 1996 to 46.7 in 1998) and Jordan
(increase from 7.6 in 1982 to 32.8 in 1997). Under-reporting of breast cancer
cases is suspected. Many differences with respect to age, biological characteristics
and stages at presentation exist between countries. In the United States,
approximately 50% of all women with newly diagnosed breast cancer are older
than 63 years while in many developing countries almost half of women with
newly diagnosed breast cancer are younger than 50 years of age (Rodriguez et al.,
2001). Elsaghir et al (2007) reviewed published literature and obtained data from
cancer registries of several Arab countries. They attempted to describe the trends
and management of breast cancer in the developing Arab countries. See table (4)
for a summary of findings.
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Country

Year(s)

No. of patients

ASR

Age at
presentation

Algeria
Bahrain

1990-93
1982-94

117

9.5
-

-

Mastectomy rate
-

Tumor
size(cm)
70% > 2

Egypt

2002-03

Hospital-based

-

Median age 49

79.9-82%

-

Jordan
Kuwait
Saudi
Arabia
Lebanon

1997
1994-96

National
258 (National)
1430 (National)

21.3
32.8
11.2

78% < 50
48.3

-

-

1964

Hospital-based
1094
2673
2092

20
30.6

-Medianage
49,
49% < 50
Medianage5,
50% < 50
-

-

-

I: 9%; II: 44%; III:
30%; IV: 16%
-

65%

4.6

III: 34.9%; IV: 15.8%

-

70%

3.9

88%

-

-

I: 23%; II: 43%; III:
33%; IV: 2%
(+ve LNs 53%)
-

Morocco
Oman

1984
1982-20
1998
1986-87
1993-97

Palestine

1995

-

Syria

1998-99

230

13.6 in Arabs
vs 102.2 in
Jews
30.4

Tunisia

1994

689

16.7

Average 50

82.40%

4.95

Yemen

1989-96

225

-

69% < 50

-

-

5148
1809

46.7
13

Stage
I: 6.8%; II: 51.3%; III:
21.4%; IV: 11.1%
III and; IV: 68%

T1: 7.2%;T2: 48.9%;
T3: 18.5%;
T4: 23.4%; CIS: 3.3%;
M1:22.1%
-

Table 4: Clinical data for breast cancer in Arab countries
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Ref.
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Ghosn et al., 1992
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Shamseddine et al., 2004
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Al-lawati et al., 1999
Al-Moundhri et al., 2004
Nissan et al., 2004

Semaan et al., 2003,
Mzayek et al., 2002
Maalej et al., 1999

Abdul Hamid et al., 2001

Breast cancer that presents at a younger age generally has more aggressive
cellular features resulting in more aggressive clinical behavior, a more advanced
stage at presentation, and poorer prognosis (Swanson & Lin, 1994). A study
conducted in southern Iran showed a relatively low five-year survival rate of
breast cancer (Rezaianzadeh et al., 2009). The study also considered 44 different
influencing factors of survival and suggested that the survival is affected mainly
by late diagnosis and therefore late stage disease. The authors hypothesized that
delay in presentation to treatment and late diagnosis is due to lack of awareness,
cultural barriers and access to treatment (Rezaianzadeh et al., 2009). Fakhro et al
(1999) conducted a survival analysis on Bahraini women diagnosed with breast
cancer at Alsalmaniya Hospital, Manama. They reported that 93.2% of women
were first diagnosed with disease progression beyond stage I, including 21.4% in
clinical stage III and 11.1% in clinical stage IV. Axillary lymph node involvement
was found in 50.4% of cases.
Papers from the Arab world did not only report the early age of onset of
breast cancer among women, but also described the aggressive breast cancer
phenotype in Arab women (Akhtar et al., 1993; Al Idrissi et al., 1992; Ibrahim et
al., 1998; Elsaghir et al., 2002; Abdel Rahman et al., 1993; Soliman et al., 1999).
Researchers from Tunisia reported cases of rapidly progressing breast cancer in
young women (Tabbane et al., 1977; Tabbane et al, 1985).
Factors influencing delayed presentation to treatment
In the literature, many factors were found to be influencing
delayed presentation to treatment. These factors include lack of
knowledge, psychosocial and cultural beliefs, lack of or deficient
screening programs, lack of specialized treatment facilities, poverty, lack
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of awareness, fear of disease/death and illiteracy (Lodhi et al., 2010). Factors
influencing delay are divided into two types, patient delay and system delay.
Patient delay factors may include, demographics, socio-economic, psychosocial or
cultural beliefs and knowledge and awareness. System delay factors are related to
the health delivery system which result in diagnosis, referral or treatment delay of
breast cancer.
Breast Cancer Delay
Breast cancer delay (BCD) or total delay is defined as “more than three
months between symptom discovery by the patient and the beginning of definitive
treatment” (Pack & Gallo, 1938 p124). This delay influences prognosis negatively
as it is associated with an advanced stage of the disease at presentation and with a
reduced chance of survival (Richards et al., 1999). Pack and Gallo (1938)
proposed the conventional classification of BCD. (1) Patient delay and (2)
Provider delay. Patient delay is defined as the time elapsed from the discovery of
symptom by the patient to first medical consultation. Provider delay is defined as
more than one month between the first medical consultation and the initiation of
definitive treatment (Pack & Gallo, 1938).
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Unger & Infante (2009) schematized the conventional classification of
delay proposed by Pack & Gallo in 1938, figure (6). The white boxes in the
middle of the diagram are the most important steps in a cancer patient’s helpseeking trajectory, represented linearly as is generally conceived in the literature.
A triple-line bar cuts the two types of delay, patient and provider, to represent that
each type has traditionally been studied independently. That is, any delay between
symptom discovery and first medical consultation has implicitly been considered
to be the patient’s responsibility. In the same way, delay occurring after the first
medical consultation has been assumed to be the health providers’ responsibility.

Figure 6: Conventional classification of delay

Patient delay
Health care services access, utilization and Socio-economic factors
Socioeconomic status is influential in a woman’s health. Evidence
showed that women with late stage breast cancer often live in poverty and
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in low income communities and act as care providers both in their families and in
the larger community (Lodhi et al., 2010). A low level of education and low
socio-economic status leads to poor uptake of screening by women. Women with
low socio-economic status are more likely to be diagnosed with advanced breast
cancer compared to more economically privileged women (Miller et al., 2002).
Regardless of age or ethnicity, poverty has a strong effect on the probability of
being diagnosed at an advanced stage (Campbell et al., 2009). Yusuf et al. (2001)
conducted a study on 400 Pakistani women with breast disease, and almost 33%
mentioned economic factors as their reason for delay in seeking help.
Access to health care services, utilization and insurance play a major role
in prolonged delay (Rauscher et al., 2010). Recommendations for improving
access to screening facilities involve two approaches: reducing structural barriers
and reducing out-of-pocket costs. Health insurance plays a major role in reducing
costs of screening paid by women and increasing the compliance with screening
guidelines (Baron et al., 2008). The benefit of providing access cannot be fully
realized if women are not aware of breast cancer screening needs and options, or
are resistant to screening. Healthcare providers should avoid missing opportunities
to discuss screening recommendations with women and be proactive rather than
passive and to offer options during healthcare visits.
Some studies investigated the demographic factors of women presenting
late for medical treatment. It was observed that women were more likely to be
diagnosed in later stages if they were older (50 years and above) or postmenopausal women, in lower income areas, delay was seen in widowed, divorced
or unmarried women who have lower educational level (Ali et al., 2008).
Unmarried women have longer duration of symptoms before seeking help unlike
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married women; this might be due to the lack of family support or the spouse to
seek help when symptoms start. Married women have the ability to rely on their
husbands for household support in order to have time to go for screening or to
seek help. For women with low socio-economic status, their spouses usually
provide economic support for the family.
Psychosocial factors and cultural beliefs
Psychosocial factors and cultural beliefs create variation in the
reaction to initial breast cancer symptoms. Painless lumps, as an initial
breast cancer symptom is an important determinant of delayed response to
the disease. The association of late presentation with painless breast lump
is related to the social and cultural belief of women that painless breast
lumps hve no danger to life and pain is the body’s language to alert
individuals to seek help (Lodhi et al, 2010). Misconception of breast
lumps is common among women who are defined as disadvantaged, ethnic
minorities with lower socioeconomic status and poorer access to care
(Rauscher et al, 2010). Yau et al (2010) stated that there are two
psychological reasons why patients delay seeking medical attention,
namely optimistic bias or defensive bias which leads to psychological
minimization of threat and immobilization by fear, embarrassment, or
denial after recognizing the seriousness of the symptom. Perception that
cancer is not curable and surgical intervention promotes the spread of
cancer and fear of losing a body part by surgery are factors which have
been addressed by many researchers. Lamptey et al (2009) reported that
women’s fear of mastectomy (surgical removal of the breast) is the main
reason for women to abscond from hospitals in Nigeria after diagnosis.
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Many women link mastectomy to death. This is often due to the lack of proper
counseling at diagnosis and the lack of support services that offer the opportunity
to express fears. Lamptey et al. (2009) supported the idea of offering newly
diagnosed women the chance to meet and talk with breast cancer survivors to
overcome the issue of absconding from hospitals. Other psychosocial common
behaviors described in the literature are spiritual healing and prayer to cure breast
cancer. Resorting to alternative medicine is a common practice worldwide. In the
USA, 28% of early diagnosed breast cancer patients are known to utilize various
forms of alternative medicine while on medical treatment (Lamptey et al., 2009).
Women in developing countries often opt for alternative treatment as the first
choice, e.g., traditional healers and spiritualists, a standard medical treatment is
used as a last resort when the disease becomes more advanced with obvious
symptoms such as discharging fungating breast lumps. The reasons for seeking
alternative treatment are various, and for some it offers a convenient escape from
mastectomy or is an extension of denial. Other reasons may be that alternative
medicine is accessible and affordable by many women especially those in low
socio-economic status (Ukwenya et al., 2008). Other psychosocial factors include
a non-serious attitude to seeking help, a hesitation to seek help and disclose
symptoms to strangers, and shyness regarding male doctors (Khan et al., 2008).
Many women are keener to seek unconventional therapies and herbal treatment
rather than medical treatment (Lodhi et al, 2010). One of the main causes of this is
a lack of trust in medical treatment and local healthcare providers or a failure to
provide female physicians in gender sensitive communities (Rauscher et al, 2010).
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Knowledge and awareness
Although awareness is something of an elusive concept, it
nevertheless influences the disease outcome. A great majority of women
diagnosed with breast cancer are symptomatic at the time of diagnosis,
probably with no access to screening mammography. Therefore, the effect
of awareness about other breast cancer screening methods such as BSE
and CBE would have a great impact on women’s health in countries with
limited resources. Breast cancer awareness, examination and screening
practices of women presenting with newly diagnosed breast cancer is
generally poor. Linsell et al (2008a) reported that older women are less
aware about the symptoms and risk of breast cancer than younger women.
Based on the survey carried out in the same study for women aged 60 to
80 years, 50% of women believed that the life time risk of developing
breast cancer is less than 1 in 100 women and 75% were not aware that
age is a risk factor.
Stockton et al. (1997) reported that in the UK during the 1980s
before the introduction of the national screening program, public
awareness was increased through public education and messages about
early detection and this resulted in a dramatic decrease in advanced breast
cancer cases in the following years. One important message to be
disseminated through public awareness campaigns is that breast cancer is
not rapidly fatal if diagnosed early. New techniques for diagnosis and
advanced treatment modalities could enable women to survive breast
cancer for longer period of time (Smith et al, 2006). Linsell et al. (2009)
stressed the importance of awareness and knowledge of breast cancer
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symptoms and risk factors in promoting early presentation to treatment. Lack of
awareness about risk factors, initial symptoms, screening and treatment was one
of the major findings of many research targeting the factors affecting delayed
presentation of women to treatment (Lodhi et al, 2010). The effective and timely
diagnosis of breast cancer relies on breast health awareness. Thus, increased
breast health awareness is an important key element of intervention at all resource
levels including countries with limited resources. Linsell et al (2009) claim that
breast cancer awareness programs, which include breast cancer knowledge and the
confidence, skills and motivation needed to self-detect symptoms and seek help
accordingly, reduce delays in presentation. Symptoms interpretation, the initial
and most important step in symptom recognition, is highly affected by breast
cancer perceived risk and symptoms knowledge regarding breast cancer (Lim &
Edlin, 2009). When the symptom is inconsistent with women’s lay knowledge of
breast cancer, women are more likely to downplay the significance of minimal
symptoms and delay seeking medical care (Lim & Edlin, 2009). Pineros et al
(2009) reported that approximately 40% of women delay in seeking help due to
lack of knowledge about initial breast cancer symptoms and they do not consider
symptoms to be important. Taj et al (2009) recommend the use of breast clinics in
hospitals and the utilization of the mass media to promote awareness.
Provider / System delay
Many studies discuss the patient delay factors, however, provider delay
from diagnosis to start of treatment has not been fully examined. Delays in the
diagnosis process, referral of women after diagnosis or delay in treatment
initiation is likely to result in tumor progression and poor prognosis (Arndt et al.,
2003). Provider delay has been further divided by some authors into (1) diagnosis
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delay, time between the first clinical consultation and cancer diagnosis,
and (2) treatment delay, time between diagnosis and beginning of
treatment (Caplan et al., 1996 & Gwyn et al., 2004). Although less
frequently, it has also been divided into (1) referral or general practitioner
delay; time elapsed between first consultation to a primary care service
and referral to a hospital, and (2) hospital delay, time from referral to
beginning of definitive cancer treatment (MacArthur & Smith, 1981;
Sainsbury et al., 1999). Arndt et al (2003) conducted a population based
study on provider delay among breast cancer patients in Germany. 380
women diagnosed with breast cancer were interviewed to discuss the
diagnostic process they went through. Median provider delay was found
to be 15 days and did not differ by physician specialty in the first visit.
Delays in diagnostic work up were found to be related to the erroneous
initial suspicion of a benign breast disease. Other reasons were time
constraints by patient or physician. Provider delay over 3 months was
found in 11% of all breast cancer cases and was associated with patient
characteristics such as lower education, full time employment and
presenting with a non-breast symptom. Bright et al. (2011) conducted a
study in Mexico to examine the role of health system factors in delaying
final diagnosis and treatment of breast cancer. 32 patients were
interviewed using a semi-structured questionnaire. Participants were asked
to provide an account of what took place between the discovery of a breast
symptom/sign and subsequent primary, secondary, and specialty clinic
visits. Results showed prolonged delay. Women interviewed in this study
experienced a total diagnostic delay of 7.8 months and a total treatment
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delay of 8.4 months. The average delay from symptom discovery to first
consultation was shorter (1.8 months) and mainly related to patient factors. In
Scotland, Baughan et al (2009) conducted a two year audit to follow the diagnosis
of cancer and referral. The audit included all types of cancer and 4181 patients
were identified in the first year and 12, 294 in the second year. The priority with
which general practitioner referred patients varied considerably between tumor
groups (77.5% of breast cancer cases were deemed ‘urgent’ compared with
44.7% of prostate cancer cases). The proportion of cancer patients being referred
urgently increased from 46% to 58% between the first and second audit. Finally,
they concluded that there are very different patterns of presentation and referral of
patients. Following a unified care pathway may greatly help in reducing these
differences.
Factors influencing late presentation for breast cancer in the Middle East
Many reviews have been conducted to examine the factors explaining
breast cancer delay. However, none of these reviews have specifically addressed
the evidence in the Middle East (Alhuraishi et al., 2011). Alhuraishi et al. (2011)
conducted a systematic review to assess and examine the strength of the factors
influencing breast cancer delayed presentation in the Middle East. They adopted a
strength of evidence assessment tool developed by Ramirez et al. (1999) to assess
studies selected for the review.
On assessing the influencing factors for delayed presentation, Alhurishi et
al. (2011) found that there is strong evidence supporting the effects of older age
and lower educational level on late presentation. The strength of evidence on the
effects of family history, marital status and presence of symptoms other than
lumps was moderate.
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Screening and early detection
Screening is the only available way to detect the cancer in its early
stages. Delayed presentation to treatment and the underutilization of
screening services are closely connected to women’s knowledge of breast
cancer and available screening methods. Screening methods recommended
for early detection of breast cancer include BSE, CBE and mammography.
CBE and mammography require visiting the hospital or clinic to be
performed by specialized healthcare staff but BSE is conducted by the
woman herself and it is cost-effective if performed correctly.
Okobia et al (2006) tried to account for the 70% late presentation in
Nigerian women through a cross sectional survey aimed to assess the knowledge
level of Nigerian women regarding breast cancer and screening methods. In the
study sample, the mean knowledge score was 42.3%. They found significant level
of ignorance about risk factors and common symptoms of breast cancer. The use
of screening methods was very low among the study subjects, only 34.9% practice
BSE and only 9.1% had had CBE in the past year and none had ever had a
mammogram. They concluded that routine breast cancer screening is rarely
practiced in Nigeria.
Another study done in Malaysia by Kanaga et al (2011) showed
differences in awareness of screening procedures between women living in urban
and rural areas. They also reported a significant positive relationship between
awareness and education level. Dahlui et al (2013) investigated the knowledge of
Malaysian women about screening procedures and practices. The uptake of BSE,
CBE and mammogram was 59%, 51% and 6.8%, respectively. Noroozi &
Tahmasebi (2011) reported the poor practice of BSE among Iranian women. Their
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result showed that only 7.5% of women in their study monthly practiced BSE
monthly and 14.3% reported having at least one mammogram in their lifetime.
Breast cancer screening practices among Arab women
Donnelly and Hwang (2013) performed a literature review of studies in
the Arab world addressing screening practices. They included studies from Arab
countries in North Africa (Egypt & Sudan), the Eastern Mediterranean region and
the Arab peninsula. Because screening programs in the Arab world are new and
opportunistic in nature, few studies have been published regarding the
participation rate in screening activities. Table (5) summarizes all studies found in
the Arab world reporting women participation rates. All studies reported low
participation rates.
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Region

Country

Main study outcome

Author (s)

Arab peninsula

UAE

12.7% of 1367 women
practiced BSE, 13.8% had
undergone CBE, 10.3% had
undergone mammography.
24.9% of 1200 Qatari women
aged 30–55 practiced BSE,
23.3% underwent CBE, 22.5%
underwent mammography.

Bener et al., 2001

23.1% of 719 women
practiced BSE, 14.2 had
undergone CBE, 8.1%, had
mammogram.

Rachivandran et
al., 2011

5.7% of 1315 women age 4050 and 21.1% of women aged
>50 adhering to screening of
CBE and mammography
according to age specified
guidelines.

Amin et al., 2009

Of 700 women, 20.5% had
breast cancer screening. 79%
heard of BSE, 47% knew how
to perform BSE.

Radi, 2013

17.4% of 500 university
students practiced BSE.

Ahmed, 2010

Qatar

KSA

Yemen
Eastern

Jordan

7% of 519 Jordanian women
practiced BSE regularly.

Bener et al., 2009

Petro-Nustas and
Mikhail, 2002

Mediterranean

Palestine

Lebanon

397 Palestinian women aged
50, more than 60% had never
attended mammography, 18%
had ever attended
mammography, 28% had ever
undergone CBE.

Azaiza et al.,
2010

18% of 1200 women had
mammogram

Rachivandran et
al., 2011

44

Israel

20% of 510 Muslim Arab
women aged 50–69 had
mammography screening
according to age specified
guidelines.

Telephone survey of 1550
women, 66.8% of Arab
women and 74.2% of Jewish
women had
undergone mammography
during the
past 2 years.

North Africa

Sudan

Egypt

CBE participation rates were
69.5% for 305 Arab Muslim
women, 88.7% for 159
Christian women, 65.4% for
104 Druze women.
Mammography rates were
39.7% for Muslims, 58% for
Christians, and 36.6% for
Druze.
7.2% of 200 medical students
practiced BSE, 66.5% had
heard of BSE. In addition, of a
300 asymptomatic female
sample, 6.4% practiced BSE,
12% had heard of BSE.

10.4% of 565 women
practiced BSE, 2.7% reported
monthly BSE.

Soskolne et al.,
2007

Baron-Epel,
2009c

Azaiza and
Cohen, 2006

Abdelrahman and
Yousif, 2006

Abdel-Fattah,
2000

Table 5: Participation rate in screening activities in the Arab world
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Barriers toward breast cancer screening
Despite the proved efficacy of mammography and other screening
methods, participation rates are very low in target groups. For example, in the
state of Ontario, Canada, the participation of the target group was only 60%, while
their goal is a participation rate of 90% (Ontario Women’s Health Council, 2006).
Similarly in the UAE, in 1995, the Ministry of Health had a target participation
rate of 70% by 2013. Thirteen years later in 2008, the participation rate was only
10% (Taher et al., 2008). Barriers related to breast cancer screening have been
widely studied. Many factors influence participation in screening programs. These
factors include personal, religious, psychological, cultural, environmental and
social factors (Theisen, 2004).
Individual and community barriers
Individual barriers to breast cancer screening are numerous and diverse.
These barriers exist regardless of ethnicity, age, nationality, education level or
income level. Knowledge about the benefits of early detection has been reported
to be an important determinant for breast cancer screening (Bener et al., 2009).
Sources of knowledge varied but mainly Arab women acquired their knowledge
from healthcare providers, friends and the mass media (Montazeri et al., 2008).
Knowledge includes misconception about breast cancer and breast cancer
screening (Medline plus, 2007). Women may have misconceptions such as
believing that a state of being free of symptoms indicates absence of the disease or
exposure to mammography radiation may lead to cancer. Such misconceptions
may de-motivate women from regularly attending screening. In the UAE,
screening is widely available but participation rates remain low (Taher et al.,
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2008). Bener et al. (2009) reported that despite having knowledgeable women,
participation in breast cancer screening activities remained low.
Socioeconomic characteristics also play a major role in facilitating or
hindering participation in screening. Demographic barriers include age, education;
residence and income interchangeably play the role as barriers. Income is well
known to have an influence on screening practice especially for women living in
poverty. Surviving the day has priority over seeking screening of a perceived lowrisk disease (Powe & Finnie, 2003).
The culture and social environment of the woman plays a major role in
screening behavior. Despite higher incidence rates of breast cancer among white
women, the disease actually kills more minority women and this is attributable to
the fact that minority women are less likely to be screened (Siahpush & Singh,
2002; Baron-Epel, 2009a; Remmenick, 2006). Fatalism and fear from discovering
breast cancer were found to be major barriers to screening attitude (Seif & Aziz,
2000; AlQattan et al., 2008, Bener et al., 2009). In the UAE, Sabih et al. (2012)
reported that fear, fatalism and shyness were the most contributing factors to nonparticipation in screening activities.
In the Arab world, the role of women is often defined by marriage and
children. Exposing women to screening may lead to cancer diagnosis which
disfigures this image and role. Although Islam plays a big role in defining
different aspects of Muslims’ lives including health and illness, its impact on
health seeking behavior is controversial (Hatefnia et al., 2010). In Islam, the
individual is held responsible for his/her own health and failing to care for one’s
health is considered a sin (Hatefnia et al., 2010). Passivity regarding self-care is
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sometimes related to “ignorance about Islam’’ or deferring self-responsibility to
God, or fate (Azaiza & Cohen, 2008).
Health care providers
Healthcare providers play a major role in attracting Arab women for
screening (Montazeri et al., 2008). Bener et al. (2009) found that despite 80% of
women in the UAE being willing to have CBE; only 33% had been offered CBE
by healthcare providers. Nurses were found to lack knowledge about screening
and this discourages women from participating in its activities (Madanat &
Merrill, 2002). In Yemen, among 105 female physicians, 36.6% did not refer
asymptomatic women for mammography (Al-Naggar et al.

, 2009). The main

barriers of breast cancer screening in the Arab world are summarized in table (6).
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Barrier

Description

Country

Author

Lack or inadequate knowledge

Inadequate knowledge of breast cancer and screening
activities

Saudi Arabia, Egypt,
Jordan, Israel, Yemen,
Sudan, Iran, Palestine,
UAE

Abdelrahman & Yousif, 2006; Alam, 2006; Amin et al., 2009;
Ahmed, 2010; Aghamolaei et al., 2011; Azaiza& Cohen, 2010; Bener
et al., 2001; Dandash & Al Mohaimeed, 2007; Heidari et al., 2008;
Milaat, 2000; Montazeri et al., 2008; Seif & Aziz, 2000; Rashidi &
Rajaram, 2000; Soskolne et al., 2007

Healthcare providers knowledge and
recommendations

Health care providers were found to have inadequate
knowledge of breast cancer screening.

Jordan, Iran, Israel,
Yemen

Alkhasawneh, 2007; Jaradeen, 2010;
Haji-Mahmoodi et al., 2002;
Madanat & Merrill, 2002
Al-Naggar et al., 2009; Harirchi et al., 2009; Soskolne et al., 2007

UAE, Qatar
Israel, Saudi Arabia,
Jordan, Egypt, Israel,
Iran

Akhtar et al., 2010; Amin et al., 2009; Bener et al., 2009; Bener et al.,
2001;
Petro-Nustas, 2002; Seif & Aziz, 2000 Baron-Epel, 2009a;
Remmenick, 2006
Baron-Epel et al., 2004

Qatar, UAE, Iran,
Egypt, Iran
Turkey, Jordan, Iran,
Israel

Bener et al., 2001; Bener et al., 2009;
Hatefnia et al., 2010; Lamyian et al., 2007;
Seif& Aziz, 2000
Alkhasawneh, 2007; Azaiza et al., 2010;
Cam & Gvmvs, 2009; Petro-Nustas, 2002

Professional recommendation was found to be an
important facilitator however low percentages of
health care providers were found to provide
recommendation for breast cancer screening.
Culture and religion

Cost and accessibility

Informal social support-objection of spouse to breast
cancer screening only mentioned by small minority.
Fear of breast cancer diagnosis as a barrier
Fear of losing traditional role as woman as a result of
cancer diagnosis.
Embarrassment regarding breast cancer screening
activities.
Fear of gossip regarding breast screening practices.
Religious influences regarding breast cancer
screening.
Accessibility to breast cancer screening facilities.
Cost and lack of health insurance to cover breast
cancer screening as barrier

Table 6: Summary of main barriers for Breast Cancer screening in the Arab World
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Conceptual framework
This part of the thesis attempts to develop a meaningful understanding of
the interaction of the contributing factors to breast cancer delay and the outcome
of the decision to delay taken by women within the context of several theoretical
frameworks which can be used to identify an appropriate model to guide the
analysis of the qualitative part of the thesis. In order to develop a model to guide
this study, it has to be derived from a broader evaluation perspective. A deductive
reasoning process was used. It involves starting with the general picture through
evaluating and critiquing existing theoretical frameworks used to guide the
analysis of previous studies. Deductive reasoning uses two or more related
concepts, that when combined, enable suggestion of relationships between the
concepts (Feldman, 1998).
No general consensus exists at this time as to which conceptual/
theoretical framework is best used to guide social health research (Lim, 2011),
especially when the cultural norms and religious practices are of great concern in
a community. Several theoretical frameworks have been applied in different
settings to investigate women’s delay for help seeking, identify factors that most
predict reasons of delay and plan appropriate interventions to prevent this delay.
Most studies of cancer delay have relied on the definition of BCD proposed by
Pack and Gallo in 1938 to draw theoretical models explaining patient delay. Lim
(2011) discussed 6 models which were developed to address delay influencing
factors. These models are (1) the Judgment to delay (Facione et al., 2002), (2)
Passive detection and help seeking model (de Nooijer et al., 2003), (3)
Understanding delayed presentation (Bish et al., 2005), (4) Care-seeking
(Reifenstein, 2007), (5) Prolonged delay models (Rauscher et al., 2010), and (6)
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Health seeking behavior and influencing factors framework (O’Mahony et al.,
2010). Most recently in 2011, (7) the Grounded Model for Health Seeking
Behavior (GMHSB) was introduced (Unger-Saldana & Infante-Castaneda, 2011).
Current models appeared to be developed for specific populations and settings,
and therefore, are not able to be generalized in other settings (Lim, 2011). The
models used different health behavioral theories or combinations of constructs and
concepts from these theories. For example, individual and interpersonal health
behavior theories were integrated with constructs to develop frameworks which
better explain and predict the behaviors associated with delay in seeking help
(Facione et al., 2002; De Nooijer et al., 2003; Bish et al., 2005; Reifenstein, 2007;
Rauscher et al., 2010; O’Mahony et al., 2010 & Unger-Saldana & InfanteCastaneda, 2011). Social and cultural interaction was applied in many models.
However, none of the models has yet used community and group theories in their
design given that patient delay for medical care of breast cancer requires
intervention at the community level (Lim, 2011). Significant constructs within
these models can be adopted and integrated to form new models appropriate to
other settings or contexts.
Individual and Interpersonal health behavior theories
Health behaviors have played an important role in health and illness.
Individual and interpersonal beliefs shape the overall understanding of diseases.
In the process for developing this study’s conceptual framework some relative
individual and interpersonal health behavior theories were reviewed. These
theories were also used in previously developed models and were helpful in
understanding individual and group health behaviors.
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Individual health behavior theories
Health Belief Model (HBM)
The Health Belief Model (HBM) is one of the first models used to
explain behaviors. It helped to guide the search for why behaviors occur
and the areas for possible change. The main constructs of this model are
four: 1) perceived susceptibility, that is, a person’s belief about getting a
certain condition, 2) perceived severity, that is, a person’s belief about
how serious this condition is, 3) perceived benefits, a person’s belief about
the effectiveness of some advised action to reduce the risk of seriousness,
4) perceived barriers, that is, a person’s belief about the concrete and
psychological costs of this advised action. The HBM is often applied to
preventable disease with early screening like breast cancer (Glanz et al.,
2008). For some individuals, the belief that cancer always causes
recognizable symptoms maybe a critical variable in explaining nonparticipation in breast cancer screening and that why it is of great
applicability to the UAE setting. However, symptoms are central to a
patient’s experience of disease. The HBM does not address important
social, interpersonal and contextual issues, and it may also miss important
factors that are not intrinsically health-related which play an important
role in shaping health behavior (Glanz et al, 2008). The constructs of
perceived threat (perceived susceptibility, perceived severity, perceived
barriers) and the cues of action are of great use when explaining the
women delay in seeking medical attention or in going to breast cancer
screening.
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Theory of reasoned action
In this theory, a specific behavior is a function of two factors: 1) an
attitude which can be positive or negative toward the behavior, and 2) the
influence of the social environment on the behavior. The attitude toward the
behavior is determined by the person’s belief that a given outcome will occur if
he/she performs the behavior and by evaluating the outcome. The social
environment or the normative belief is determined by a person’s belief about what
significant others think if he/she should do and his/her motivation to comply with
their wishes.
The theory of reasoned action and the HBM share the foundation that
behavior reflects expected value. The two theories are applicable to women’s
behavior and could be used to develop a model to explain Arab and Emirati
women’s attitudes and subjective norms toward taking actions upon discovery of
symptoms.
Interpersonal health behavior theories
Social cognitive theory
Social Cognitive Theory includes factors beyond the individual, such as
environmental and social factors. Although this theory have been used widely in
health behavior change programs, health promotion and modification of unhealthy
behavior, its constructs can be useful in explaining external factors affecting
women’s decision to seek help.
Social Support Theory and community theories
Individual change is tied with the social environment and a change in the
social ecology is supportive for individual change. The social network could be
the family or friends and neighbors who socialize and appear in the individual
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community. Social groups have certain characteristics such as structural,
interactional, and functional. Community models are categorized in three
models of practice: 1) locality development, which is the formation of a
local group from cross section of members in the community who attempt
to identify and solve its own problems: 2) social planning is a task
oriented model, it involves the decision makers, organizations and policy
development: 3) social action is a mixture of both previous models, it is
task and process oriented and involves members of the community and a
large organization. Application of social support theories and community
theories are most useful in intervention designing and health education
planning, however, it can be used in explaining behaviors of women
considering the social environment and community surrounding them.
Patient Delay and Help Seeking Models for Breast Cancer
Total Patient Delay Model
Anderson et al. proposed the total patient delay model in 1995,
based on the HBM. It was the first model which attempted to investigate
why women did not present themselves to the doctor upon discovering
symptoms. They delineated help seeking for cancer symptoms in five
stages: (1) appraisal, (2) illness, (3) behavioral, (4) scheduling and (5)
treatment delays (Anderson et al., 1995). This model attributes 60% of the
delay to the first stage (appraisal delay) as the woman is evaluating the
unexplained symptom she has, this evaluation will determine the next step
the woman will take. Either to perceive the symptom as an illness and
consequently sees medical advice, or ignore the symptom and continue her
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life without seeing the necessity of seeking help. The decision is based on her
previous knowledge and expectations.
The total patient delay model is explaining the steps leading to delay in
simple practical way, however, patient delay is a complex phenomenon and the
steps of this model are too simple to tell the complete story (Lim, 2011). The
model does not sufficiently illustrate the behavior decision making process and
the influencing factors within each stage. Especially when trying to explain the
delay phenomena in a complex setting which involves several factors such as
cultural, religious, and psychosocial factors. To address this limitation, eight
models were developed to determine the factors influencing help seeking behavior
upon the discovery of breast cancer symptom(s) between 2002 and 2012.
The application of the Total Patient Delay Model is reasonable when
explaining the women’s delay of help seeking, especially the first stage, appraisal.
However, influencing factors within the stages need to be fully explained (Lim,
2011), otherwise its use will be limited.
Judgment to delay model
Developed by Facione et al. (2002), this model proposed that many
variables are observed to have a relationship with a patient’s help seeking
behavior, but how these variables interact to predict a breast cancer delay was not
previously described in a model. This model begins with the assumption that the
symptom appraisal is a cognitive decision-making process aimed at the estimation
of potential risk posed by the symptom. It also assumes that the decision to seek
help or delay has the form of an intention formation. See figure (7).
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Figure 7: Judgment to delay model

Passive detection and help seeking model
Using a determinant model based on the theory of reasoned action, De
Nooijer et al. (2003), proposed the passive detection and help seeking model.
Their purpose was to identify factors that explained paying attention to cancer
symptoms and the intention to seek help for possible cancer symptoms within an
appropriate time. Knowledge, advantages, self-efficacy, being female and being
more highly educated were associated with passive detection. Knowledge,
advantages, moral obligation, anticipated regret, social norm, and self-efficacy
were correlated with the intention to seek help. They recommended redesigning
the educational programs to cover these two aspects (passive detection and health
seeking intention).
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Care seeking behavior
This model was developed by Reifenstein (2007) for a specific population,
namely, African American women. A number of psychosocial variables have been
proposed as factors that could affect care seeking behaviors for a breast symptom.
The psychosocial variables of fear, denial, utility (beliefs about the worth of care
seeking), and social norms have been studied by many researchers (Caplan &
Helzlsouer, 1996; Dunnavant, 1995; Facione, 1993; Facione & Giancarlo, 1998;
Lauver, 1992a; Phillips et al., 1999), but the relationship of these variables to
care-seeking behaviors for a breast cancer symptom is not sufficiently understood
to allow experts to formulate interventions to correct the underlying problem.

Prolonged delay models
This model builds on Anderson’s Total patient delay model and its stages
of delay. It categorizes the measured variables into three groups:
sociodemographic variables, variables pertaining to the interpretation of
symptoms, and variables pertaining to access and utilization of health care. In this
model, sociodemographic variables affect delay primarily by influencing either
symptom interpretation or access to care (see figure 8). Within the symptom
interpretation box, it conceptualizes that misconceptions about the meaning of
breast lumps will affect whether a woman feels the need to present medically, and
that women with personal histories of benign breast problems (i.e., who have
experienced a false alarm in the past) might be more likely to hold these
misconceptions and therefore be less likely to present promptly the next time they
find a symptom. A family history of breast cancer might prompt a woman with a
self-discovered symptom either to seek help sooner or delay seeking help to avoid
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a diagnosis of breast cancer. Within the health care access and utilization box, it
conceptualizes that absence of insurance may lead to an absence of a regular
provider, and that both of these variables will lead to fewer preventive care visits.

Figure 8: Prolonged Delay Model

Health seeking behavior and influencing factors framework
In order to gain an understanding of women’s experiences after finding a
breast symptom and how this influenced their help seeking behavior, O’Mahoney
et al (2010) proposed the health seeking behavior and influencing factors
framework. The key variables linked to delayed help seeking were denial, fear,
social factors and knowledge and beliefs. The study verified that the variables
within the “Help Seeking Behavior and Influencing Factors” framework act as
both facilitators and barriers to women’s HSB.
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Understanding Delayed Presentation Model
Developed by Bish et al. (2005), this model acknowledges that delay in
help seeking for breast cancer symptoms is influenced by a complex interaction of
demographic, clinical, cognitive, behavioral and social factors. It is not, for
example, simply lack of knowledge about breast cancer symptoms that leads to
delayed help-seeking. An explanatory model that explicitly describes the process
and its complexity would be a useful aid to understanding the influences on delay
behavior. Bish and his colleagues used the first three stages described in
Anderson’s total patient delay model (Appraisal delay, Illness delay, behavioral
delay) and added the self-regulation theory to explain the complex interaction of
several factors around them and how this influences each stage. See figure (9).

Figure 9: Understanding Delayed Presentation Model

The grounded model of help-seeking behavior (GMHSB)
The grounded model of help seeking behavior (GMHSB) illustrated in
figure (23) was developed by Unger-Saldana & Infante-Castaneda (2011). They
used constructs from the illness behavior theory which had never been in other
models. They note the dereliction in the conventional classification of delay which
is widely used in many studies and based on empirical time cut-offs that were
established arbitrarily. Moreover, breast cancer delay studies aggregate diverse
biases that have obstructed a meaningful understanding of the influencing factors
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of delay through separating the patient delay concept from provider delay as this
is pretty much integrated and well connected (Unger-Saldana & InfanteCastaneda, 2011).

The illness behavior theory
Mechanic (1995 p 15) defined illness behavior as the “ varying ways
individuals respond to bodily indications, how they monitor internal states, define
and interpret symptoms, make attributions, take remedial actions and utilize
various sources of formal and informal care.” Illness behavior has been
extensively studied during the past 50 years. The illness behavior was explained
by a simple interaction between the patient and the physician, with each party
having his/her own obligations and duties. The resolution of sickness, acute or
chronic, depends on effective interaction and communication among all the
participants of the illness event as well as physiological intervention. This simple
and efficient approach to define illness behavior lacked the focus on wider issues
of social, psychological and cultural sources of behavior. The interaction will be
neither effective, nor productive. Later on it developed to include different other
aspects, its micro-sociological concepts were modified and broadened to include
economic, cultural, psycho-social, structural, demographic, geographical and
organizational factors which affect the individual reaction to illness. The concept
has grown to encompass both macrosocial and microsocial aspects of health
seeking or illness-avoidance behavior (Young, 2004). Perception of illness is the
first step to behavior. Much of illness behavior is really coping with perceived
illness before the initiation of physician contact (Young, 2004).
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Unger-Saldana & Infante-Castaneda (2011) have developed the (GMHSB)
(see figure 10) based on the different multidimensional approaches discussed by
Young (2004) and using different relevant illness behavior concepts. These
concepts were then used in the analysis of qualitative study interviews and then
built on a theoretical model of health seeking behavior. The model comprises 4
dimensions, which were found to be the most important in the interviewees’ helpseeking trajectories: 1) the context: social, economic, cultural, family-related, and
health system, 2) the woman’s symptom interpretation and decision-making
processes, 3) the social network’s influences, and 4) health services utilization.
Context is represented as occurring prior to the other dimensions and exerting an
important influence across all of them. Symptom interpretation is placed at the
bottom of the diagram, representing that it is the most immediate process to the
patient, as it takes place inside of her. The social network comprises the second
level, and health service utilization is at the top level, farthest away from the
individual. The patient goes back and forth between these three levels. Every
interaction with another person, lay or healer, as well as the passing of time, has
an influence on symptom interpretation and subsequent help-seeking behavior.
With this overview in mind, these dimensions will be explained in greater details.
The experience of Mexican women used in the qualitative study which
drew the GMHSB is similar to Emirati and Arab women in the UAE and the
Middle East. The four dimensions used could form a foundation for this study’s
theoretical framework, especially the women’s symptom interpretation and
decision making dimension. Other constructs from different theories could also be
used.
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Figure 10: The grounded model of help-seeking behavior

Dimension (1): The context
The context includes the interaction of groups and individuals from
different classes in the society. The culture, knowledge and social network is
impeded in this context and it is very indicative and influential to symptom
recognition and the decision making process. The patient’s knowledge and beliefs
regarding life and illness and attitudes toward and availability of health services
influence the symptom interpretation and decision making at the individual level
(Young, 2004). In the GMHSB, the context has an effect on all the other three
dimensions, and the authors explain that the patient’s contextual characteristics
determine his knowledge and beliefs regarding life and disease, his social network
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knowledge, beliefs, habits and interrelations and the availability and accessibility
of different healers (Unger-Saldana & Infante-Castaneda, 2011). In this context,
social, economic and cultural factors interact and health services characteristics
which contribute to delay.
Dimension (2): Symptom interpretation and Decision making
In this dimension many factors interact together and the contextual
characteristics play a major role in taking the decision to whether seek or not seek
medical treatment. Anderson and colleagues proposed the total patient delay
model in 1995, which was the first model which attempted to investigate why
women did not present themselves to the doctor upon self-discovering symptoms.
They delineated help seeking for cancer symptoms in five stages; appraisal,
illness, behavioral, scheduling and treatment delays (Anderson et al., 1995). The
appraisal stage was used in most of the subsequent models. Appraisal delay was
found to be the major stage in patient delay, accounting for 60% of the total
patient delay. However, the illness delay is often difficult to distinguish from
appraisal delay but usually when the model is used, the behavioral, scheduling and
treatment is simple to distinguish. Moreover, the model does not sufficiently
illustrate the influencing factors within each stage. But again, as countered by
Unger-Saldana and Infante-Castaneda (2011), this is a conventional classification
of delay and it separates between patient delay and provider delay in a
chronological way.
Dimension (3): The social network interactions
Cockerham (2000) defined social networks as “social relationships a
person has during day-to-day interaction that serve as the normal avenue for the
exchange of opinion, information, and affection” (Cockerham 2000). This social
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network has great influence in the women lives. It influences their decision to
seek help and their views of healthcare availability and accessibility. The social
network knowledge, beliefs, habits and interaction with the women have an
influence on symptom interpretation and decision making. The social network of a
woman could enhance or obstruct her path of seeking help (Young, 2004).
Dimension (4): Health service utilization
In this dimension, issues of accessibility and quality of health
services offered to women once they decide to consult formally about their
symptom is a very important determinant for timely medical treatment.
Characteristics of local health services in combination with the woman’s
contextual characteristics and the effect of social network determine what
kind of services are used (Unger-Saldana & Infante-Castaneda, 2011).
After reviewing the above model and theories, a larger
understanding of the constructs and dimensions used in every one of them
was developed. Moreover, the literature review conducted and the
personal experience of the researcher with Arab and Emirate women with
breast cancer presentation to treatment, gave a basis for what constructs
could be utilized to develop a model to be used in the conduction and
analysis of interviews. The GMHSB allows for different combination of
factors at various levels to explain delay. Especially in our setting in the
UAE, many factors play different roles in the woman’s journey of disease,
and a dynamic model that allows possible interaction between different
factors at various levels needs to be adopted in an attempt to understand
this delay. The GMHSB is a well-constructed model, however, the
structural characteristics of the health system in Mexico is overrepresented
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in the model as a result of over discussing it by interviewees and this was
mentioned by the authors as a limitation of the model. They are interested to know
the applicability of the model in a different setting where the financial burden on
patients is limited or nonexistent. The UAE health system is thought to be of
interest as discussed earlier in this thesis, as all residents and national citizens of
the UAE enjoy excellent health coverage and the financial aspect plays a small or
limited role in the decision making of women to seek help. Another limitation of
the model discussed by the authors is the interviewees they purposefully selected
are those who were privileged in their ability to reach the public cancer hospital,
many others due to different circumstances were not able to access the hospital.
Therefore women interviewed are not representative of the uninsured Mexican
population. Furthermore, women were interviewed first when they reached the
hospital at the beginning of their treatment journey, and the confirmation of breast
cancer diagnosis was made after that. As a result, not all women interviewed had
positive cancer biopsy. Moreover, other factors that interfere between hospital
admission and the beginning of treatment were unidentified. To overcome these
limitations, our participants were chose purposefully from the regional oncology
center at the end of their treatment.
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The proposed model for this study
Health seeking model
Applicability of models for UAE setting
Few qualitative studies have been conducted in the Arab world. All of
these studies were merely descriptive in nature and lacking a theoretical
framework (Abdel-Fatah et al., 1999; Elzawawy, 1999; Elzawawy, 1991; Harirchi
et al., 2005; Harirchi et al., 2005; Stapleton et al., 2010). The majority of BCD
research has an empirical scientific approach and has described mainly its relation
to survival, factors associated to patient delay, and provider delay factors
(Ramirez et al., 1999; Richards, Westcombe et al., 1999b; Unger-Saldaña &
Infante- Castañeda, 2009). Most studies that include theoretical frameworks base
their analysis on psychological theories to explain the patients reasoning for
delayed presentation (Bairati et al., 2006; Bish et al., 2005; Katapodi et al., 2005;
de Nooijer et al., 2001b). Contextual social and health system characteristics have
been ignored by most researchers investigating BCD. The illness behavior theory
can enrich the understanding of BCD through its social and psychological aspects
of health it accounts for.
The constructs of the previously explained theoretical frameworks
can be used in the development of a new model/conceptual framework
appropriate for the analysis of the qualitative study in the UAE setting
(Lim, 2011). In this study, a conceptual framework was used to guide the
analysis mainly based on the illness behavior theory and the GMHSB by
Unger-Saldana and Infante-Castaneda (2011). However, some constructs
were adopted from other models. The illness behavior theory gives a
holistic explanation of the help seeking behavior in the case of illness. It
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also discusses the determinants of the help seeking behavior. The developed
conceptual framework (see figure 11) shows the interactions of the breast cancer
patient at three levels: a) the individual level, including symptom recognition and
symptom appraisal, b) the community and social network level, and c) the
healthcare delivery system level. The first level uses four aspects identified in
Bish’s model: 1) Knowledge and symptom appraisal, 2) attitude to help seeking,
3) disclosure of symptoms and 4) intention to seek help. These four aspects
interact together to influence patient behavior. At level one, the individual
evaluates and interprets the recognized symptom(s) and her perception as being
sick or unwell as a prelude to seeking help. At the second level, the social and
community network is represented within the environment. This includes the
woman’s family, her husband (for married women), neighbors and friends. The
interaction of the first two levels, the individual level and the community-social
network level in the environment, guides the woman in decision making, i.e.
whether to seek help or to ignore the symptom(s). If the woman decides to seek
help, then the third level, the healthcare services utilization (healthcare delivery
level), will influence the two previous levels. The third level includes aspects such
as acceptability, errors in diagnosis and the referral process.

67

Figure 11: Conceptual framework (The help seeking model)
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Chapter four
MATERIALS AND METHODS

Study location
The oasis city of Al Ain (Figure 12) is the second largest city in
the emirate of Abu Dhabi and the fourth largest city in the UAE. With an
estimated population of 631,000 in mid-2012 (Statistics Center, Abu
Dhabi, 2013), it is located approximately 160 km east of the capital Abu
Dhabi and about 120 km south of Dubai. It represents about 27% of the
total population of the emirate of Abu Dhabi and also represents 35.5% of
the female population in the capital.

Figure 12: Map of the UAE
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Tawam Hospital cancer registry
Tawam Hospital serves as a regional referral center for specialized
medical care and is a national referral center for oncology services. Tawam
Hospital received program accreditation in 2012 from the American College of
Graduate Medical Education – International, and is a recognized intern, resident,
and fellowship training site for the Arab Board. Tawam Hospital started its
services in September 1979; radiotherapy became available for the first time in the
UAE. In February 1983, oncologists in the UAE and the Ministry of Health
recommended the Tawam Hospital in Abu Dhabi emirate as the cancer referral
hospital in the country (Tadmouri & Al-Sharhan, 2004). Within Tawam Hospital,
the cancer registry is considered to be an integral part of the hospital's cancer
program which serves the needs of the hospital administration, the hospital's
cancer committee, other hospital staff and researchers. Tawam cancer registry
plays an important role in measuring cancer care delivery and supports quality
improvement studies at the hospital. Tawam cancer registry systematically
collects, electronically stores, summarizes and disseminates information about
cancer patients who are diagnosed and/or treated at the hospital. The data
collected by the registry describe both the patient and the disease and includes
patient demographics, tumor information, staging information, cancer treatment
and follow up. In 2012, Tawam Hospital signed a service level agreement with
the Ministry of Health UAE to perform cancer data abstraction services required
to operate the National Cancer Registry. Moreover, Tawam Hospital has taken a
leap to establish Abu Dhabi Central Cancer Registry (ADCCR) as main hub for
cancer data collection from all hospitals in the emirate of Abu Dhabi to submit
cancer data to Central Cancer Registry Abu Dhabi. It is anticipated that the
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structure will be fully operated and the process will start running
effectively from 2013 onwards. Tawam Hospital cancer registry is the
only hospital based registry in the country which collects, process,
analyses and disseminates data on newly diagnosed cancer on patients
diagnosed or treated at Tawam Hospital. Tawam hospital data remains the
main source of cancer statistic

The study was carried out in three phases.
Phase I (descriptive)
Study design
The first phase is a descriptive epidemiological study aimed at describing
breast cancer trends and patterns of presentation in the UAE. There is insufficient
data on breast cancer incidence and mortality rates and the national cancer registry
is still under development and will provide data on cancer epidemiology in the
future. Hence, data used in this study were extracted from Tawam Hospital cancer
registry. Data included age at diagnosis, clinical and pathological stage, TNM
staging, grade and differentiation, date of initial treatment, first and consecutive
course of treatment, last date of contact and vital status.
Study population
Our study looked at clinical presentation and survival analyses of all cases
of breast cancer occurring between January 1, 2008 and December 31, 2012 and
which were registered in Abu Dhabi Central Cancer Registry database (HAAD).
A retrospective review of data was undertaken by the cancer registry staff.
Information on patients’ age, date of initial diagnosis, date of treatment initiation,
TNM staging, last contact date, and vital status were obtained.
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Data collection tools and process
The staff of Tawam Hospital cancer registry use a predefined tool for an
annual breast cancer data audit. Data were requested for five years (2008-2012).
The data was received in Excel format. The total number of cases was 1,611
breast cancer diagnosed or treated in Tawam Hospital during the period of 5
years. For quality check, the principal investigator reviewed a random sample of
150 medical records of breast cancer patients independently. No inconsistencies
were noted.
Data management
All information obtained from Abu Dhabi Central Cancer Registry was
inputted into personal computer by the principal investigator. Data were analyzed
with the Statistical Package for the Social Science (SPSS) version 20. Frequency
checks were done randomly to minimize the likelihood of errors in data entry.
Consultation with department biostatistician was made throughout the conduction
of the study and especially during the process of data analysis. Both descriptive
and analytical statistics were used. Frequency tables, charts and diagrams were
used to describe the data obtained from cancer registry. Survival curves were also
used.
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Phase II (qualitative)
Study design
The second phase is a qualitative study conducted among breast cancer
survivors treated in Tawam Hospital. Thematic/template analysis was used with
the help of a proposed thematic framework to explore women’s reasons for delay
in seeking medical advice for self-detected breast cancer symptoms, and their help
seeking trajectories. With the use of the semi-structured interview guide and the
flexibility of the interviewing process, large quantities of rich data were expected
to be collected. Template analysis is a relatively recent development in qualitative
data analysis. This emerged from more structured approaches such as grounded
theory and interpretative phenomenological analysis (Waring & Wainwright,
2008) with the difference that it involves the use of a priori defined set of codes.
Template Analysis appears to have emerged from the USA during the 1990s and
academics familiar with the Grounded Theory approach to data analysis may see
similarities in the techniques used. It is now used in the UK in health and
sociology related fields. Template analysis starts with some predefined codes
intended to help guide analysis (King, 2004). In this study, a priori codes from the
thematic framework were adopted. The process involved in-depth confidential
person-to-person interviews. This was the preferred method for acquiring data as
it involved questions that may be perceived to be ‘sensitive’ (Kvale, 1996). In
depth interviews help explore very sensitive, embarrassing, controversial or
“personal” topics such as breast cancer, it also assist the researcher to understand
differences within target segments and gain detailed, in-depth individual
understanding of the phenomenon. In-depth interviews are preferred over focused
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group interviews because they eliminate any potential for interpersonal bias. They
are also convenient when trying to study hard to recruit participants.
Study population
Women who were first diagnosed as stage IIB and III based on the AJCC
classification were selected to participate in the study. To reduce recall bias, only
women who were diagnosed recently (i.e. in 2010 and 2011) were selected for the
study. Participants were either UAE nationals or non-national women of Arabic
origin presenting between January 1, 2010 and December 31, 2011 at Tawam
Hospital, Al-Ain, United Arab Emirates.
Data collection tools and process
Interview guide was adopted to steer the conversations however,
interviews were semi-structured to allow for emerging concepts and to generate
rich data. The interview guide (appendix 4) traces the journey of the patient from
discovery of symptom(s) of breast disease to their present state of health. A list of
all eligible participants was generated from Tawam hospital patient records.
Purposive sampling of breast cancer survivors was conducted to gain a diverse
range of perspectives and to ensure the inclusion of women from different age
groups, ethnicity and educational status. Sampling was continued until data
saturation was attained. These women were chosen from the breast center,
radiotherapy, oncology clinic, local breast cancer support groups and from Tawam
Hospital database.
Recruitment was carried out via telephone calls after extracting potential
participants’ phone numbers from the Tawam Hospital database. Two further
attempts were made to contact non-responders to the initial phone call. Following
agreement to participate, the participants had several follow-up phone
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conversations with the interviewer to improve interviewer-participant rapport and
to help retain interest and participation in the research. Women who agreed to be
interviewed were asked to choose a convenient venue of their choice for the
interview. Conducting the interviews in the participants’ homes was initially
considered but later found to be not feasible, as an additional layer of approval
from the husband or head of family was required. The interviews were therefore
conducted in a local hospital convenient to the participant. This was perceived to
be a non-threatening environment for the interviews with the participants. All
interviews were conducted in Arabic or English. The duration of interviews
ranged from 60 to 120 minutes.
Data management
The transcriptions generated from the in-depth interviews
(qualitative study) were coded and manually analyzed. No qualitative data
software was used. All transcribed data were read by the principal
investigator several times to obtain familiarity with the information
provided. The data was analyzed using the thematic/template framework
analysis method (Ritchie & Lewis, 2003). A priori defined themes and
emerging key points were identified from the thematic framework adopted
(Figure 14). An approach involving first cycle coding and second cycle
coding was used to identify emerging codes (Unger-Saldana, 2009).
Coded responses and the views and ideas of all participants were then
grouped and classified according to the priori defined themes (see figure
13) which were obtained from the developed conceptual framework for
this study. The researchers have used deductive reasoning to move from
the developed conceptual framework, which was substantiated with
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literature, to the hypotheses. The developed model has provided a framework to
guide the research from theory to hypotheses. In this study, psychosocial and
cultural issues were expected to arise in the data. It was hypothesized that the lack
of awareness about breast cancer and the cultural and psychosocial beliefs were
thought to play a major role in delayed presentation to treatment and act as
barriers for screening and early detection. The constructs used in the conceptual
framework were used to act as priori themes and they were tentative and equally
subject to redefinition or removal as any other theme.

Figure 13: Phase II data analysis process
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Phase III (cross-sectional survey)
Study design
The third phase was a descriptive community based survey/cross sectional
conducted among women living in the city of Al Ain. The aim was to assess the
breast cancer screening knowledge, attitude and practice among women at
screening age who visit community and religious centers in the city of Al Ain,
UAE. An interviewer administered questionnaire was developed using the cancer
awareness measure and was used in this study. This study will help compare
different population groups (national and non-national Arab women) at a single
point in time. Results will also be used to compare with similar studies completed
in the past.
Study population
The sample for the survey was selected from community cultural and
religious centers in Al Ain. These centers are designed as places for women to
socialize and provide an organized form of religious gatherings. Four centers were
randomly selected out of 12 centers. The centers’ management was approached
and study days were selected. Each center was visited once. All women aged 40
years and above attending the center during the study day were approached and
invited to participate. Women who agreed to participate were interviewed in order
to answer the questionnaire.
Data collection tools and process
A modified Arabic version of the Cancer Awareness Measure (CAM)
version 2.1 (Cancer research-UK, 2008) was used. The CAM validity was
evaluated by Stubbings et al. (2009), cognitive interviewing of participants in the
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validation process indicated that the CAM was being interpreted as intended with
high internal and test–retest reliability. However, to accommodate cultural
differences in the UAE setting, a few questions were added regarding breast lump
interpretation (appendix 5). The questionnaire was divided into three sections: the
first section covered socio-demographic characteristics (age, nationality,
education level, age at menarche, breastfeeding practice, use of contraception
methods and exercise), the second section was on general breast cancer
knowledge, risk factors and warning signs, and seven general questions about
breast cancer were included. A correct answer was scored as 1, a false answer or
‘don’t know’ was scored as 0. The maximum attainable score is 16. The third
section covered the knowledge, practice and attitude to regular BSE, CBE and
mammography. Questionnaires were marked based on the Cancer Awareness
Measure (CAM) version 2.1 answer sheet (Appendix 6).
Data management
Data were analyzed with the Statistical Package for the Social Science
(SPSS) version 20. Frequency checks were done randomly to minimize the
likelihood of errors in data entry. Consultation with department biostatistician was
made throughout the conduction of the study and especially during the process of
data analysis. Both descriptive and analytical statistics were used. Frequency
tables, charts and diagrams were used to describe the data obtained in phase.
The chi-square test was used to test for statistical significance when
comparing two or more proportions and the t test was used to compare two means.
Two-tailed probabilities were calculated and values of less than 0.05 were
considered significant. Multivariate analysis was then carried out by logistic
regression in which screening (History of CBE and/or Mammogram) was
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considered as the dependent variable and variables known to be barriers or
promoters for screening were used as independent covariates.
Ethical considerations
Obtaining consent
The principles behind consent include: a) the primary investigator
being knowledgeable about the consenting process and is responsible for
obtaining informed consent from the participants. b) Participants should
not feel forced to participate. c) The investigator needs to make sure that
participants understand that taking part is completely voluntary and that
they may withdraw at any time without having to provide a reason for
doing so. d) Participants must also understand that whether or not they
participate in the research study will not affect their normal standard of
healthcare or their benefits. However, due to the culture and participants’
concerns regarding confidentiality despite being provided good
explanation of protecting confidentiality, they may be reluctant to sign the
consent form and may give only verbal consent. All the three phases of
this research received ethical approval from Al Ain District Ethical
Committee.
Ethics approval
All three phases of this study received ethical approval from Al Ain
Medical District Human Research Ethics Committee before the commencement of
data collection (Appendix1, 2, 3).
Emotional distress
Emotional distress may arise during the interviews with breast
cancer survivors. Interviewees may feel emotionally distressed while
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talking about sensitive issues and life and death matters. To handle this, the
patients’ coordinator from the breast cancer center in Tawam Hospital whom the
participants know personally and who has a good relationship with patients
attended all the interviews to help with these issues as they arose. Participants’
were offered the option to withdraw from the study at any point if they wishe.
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Chapter five
RESULTS

Phase I (descriptive)
Characteristics of the sample
There were 1,611 cases registered in Abu Dhabi Central Cancer Registry
in the period between January 1, 2008 and December 31, 2012. The mean age of
all cases was 48.2 years (SD±11.8). There were 8 men (0.5%) in the sample. The
study sample comprised of 21.4% (n=344) UAE nationals and 78.6% (n=1267)
non UAE nationals. See table (7).

Nationality
UAE national Non UAE
national

Total

Total

344 (21.4%)

1267 (78.65)

1611 (100%)

15-30

20 (1.2%)

61 (3.8%)

81 (5%)

66 (4.1%)

292 (18.1%)

358 (22.2%)

105 (6.5%)

445 (27.6%)

550 (34.1%)

93 (5.8%)

290 (18%)

383 (23.8)

36 (2.2%)

137 (8.5%)

173(10.7%)

24 (1.5%)

42 (2.6%)

66 (4.1%)

Age group (years)

31-40
41-50
51-60
61-70
>71

Table 6: Distribution of breast cancer cases by nationality and age group

Data analysis showed 61.3% (989) of cases are less than 50 years of age at
diagnosis. Most cases fall between the ages of 41-50 34.1% (550) of total, see
figure (14). Socio-demographic characteristics other than nationality were not
available for analysis.
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Figure 14: Frequency distribution of breast cancer cases by age group on first
diagnosis

Tumor characteristics
Staging
American Joint Committee on Cancer guidelines (AJCC) was used for
staging of breast cancer. The majority of cases were diagnosed at stage 2A 19.9%
(320). Advanced breast cancer at stage 4 constituted 7.8% (125) of all cases. See
figure (15).
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Figure 15: Frequency distribution of breast cancer cases by clinical staging of tumor on
first diagnosis

In 52% (836) of cases the site of the tumor at presentation (laterality) was
the left breast, the right breast 46.8% (754) cases and bilateral involvement in
1.4% (19) cases, see figure (16).

Figure 16: Frequency distribution of breast cancer cases by site of the tumor on
first diagnosis

86

Grade/ Differentiation
The majority of cases had grade III/poor differentiated breast cancer
n=692 (43%). See figure (17).

Figure 17: Frequency distribution of breast cancer cases by grade &
differentiation on first diagnosis

Mammography or clinical examination reports revealed lump size at
presentation to be 26.5% (341) less than or 2cm, and majority fell between 2-5cm
52% (669), and 1.4% (18) more than 5cm, 20.1% (324) of cases had missing
information on tumor size. See figure (18).
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Figure 18: Frequency distribution of breast cancer tumor size on first diagnosis

Axillary lymph node involvement from all pathological reports revealed
92% (1482) involvement in the analyzed sample. Data on contralateral and supracalvicular lymph node involvement were not available for analysis.

Treatment
Of all cases, 83% (1337) had surgical intervention in Tawam Hospital and
74.4% (1198) had surgery and other adjuvant treatment in the hospital. The rest
17% (274) either had the surgical intervention before they were referred for
further management or they went abroad for treatment after diagnosis. Data on
type and extent of surgical intervention and neo-adjuvant chemotherapy was not
available for analysis.
Table (8), shows pathological factors by patient status at the end of the 5 year
(2008-2012). 96.7% (1558) cases were alive and 3.3% (53) died.
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Tumor
characteristics
Side
Left
Right
Bilateral
Total
Tumor grade
Poorly-differentiated
Moderately-differentiated
Well-differentiated
Total
Lymph node
Negative Lymph node
1-3 Lymph node
4-9 Lymph node
More than 10 Lymph node
Total
Tumor size
≤2 cm
2-5 cm
≥5 cm
Total

Alive

Dead

Total

N

%

N

%

N

%

805
729
10
1544

96.6
96.9
90.9
96.7

8
3
1
2

.4
.1
.1
.3

33
52
1
596

100.0
100.0
100.0
100.0

664
556
155
1375

96.1
97.4
98.7
96.9

7
5
2
4

.9
.6
.3
.1

91
71
57
419

100.0
100.0
100.0
100.0

48
297
167
78
590

98
96.1
9.4
97.5
7.4

1
12
1
2
6

2
.9
.6
.5
.6

9
09
68
0
06

100.0
100.0
100.0
100.0
100.0

246
488
200
934

96
97.2
96.2
96.7

0
14
8
32

4
8
.8
.3

56
02
08
66

100.0
100.0
100.0
100.0

Table 7: Patients’ Characteristics at diagnosis by the patient status at the end of
follow-up

Time interval in months between first diagnosis and first treatment
Most cases received treatment within one month from initial diagnosis
54.6% (880). 75.5% (1216) received treatment within 3 months and 23.5% (379)
received treatment after 4 months from initial diagnosis. Delay mean was 1.2
months from diagnosis. See figure (19).
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Figure 19: Cases distribution by time interval in months between first diagnosis
and first treatment

Kaplan-Meier survival analysis
The Kaplan-Meier estimate is one of the best options to measure the
fraction of subjects living for a certain amount of time after treatment. In this
study, survival analysis showed 3.3% (53) cancer related deaths among the total
1,611 cases in the study. Mean survival time was 18.2 months (SD 14.29).
Cumulative survival for all subjects was 96.7% after 5 years.
The hazard ratio (The hazard ratio is an expression of the hazard or chance
of events occurring in the treatment arm as a ratio of the hazard of the events
occurring in the control arm) between those who had a delay of three months and
more and those who had delay less than three months was equal to 2.36 with 95%
confidence interval of (1.045-5.35). The p value corresponding to this hazard ratio
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was equal to 0.039, which is significant at the alpha level 5%. This result has been
confirmed in a descriptive way using the Kaplan-Meier plot, see figure (20).

Figure 20: Kaplan – Meier curves according to delay

For other potential confounders such as age, lymph node involvement and
tumor size, no significant effect was found. The p values were 0.325, 0.719 and
0.19 for age at diagnosis, lymph nodes involvement and tumor size, respectively.
Kaplan-Meier curves for these variables confirm the results; see figures (21, 22).
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Figure 21: Kaplan-Meier curves according to lymph nodes involved and age at
diagnosis
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Figure 22: Kaplan-Meier curves according to tumor size
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Phase II (qualitative)
Sample characteristics
A total of 19 women were interviewed. Twelve women were UAE
nationals and seven were non Emiratis of Arabic origin. These seven nonnationals were from Iraq (2), Egypt (1), Jordan (1), Tunisia (2) and (1) Palestine.
Their socio-demographic characteristics are as shown in figure (23) and table (9).
They ranged in age from 35-70 years, with a mean age of 48.6 years (SD 11.29).
Eighteen women indicated that they had previously heard of breast cancer and
three women had a positive family history of breast cancer (i.e., breast cancer in a
close relative). The education level of participants ranged from illiteracy to
university level. The time interval between symptom discovery and seeking
medical help ranged from three months to two years (table 10). The principal
investigator and the study participants were in agreement regarding the suitability
and effectiveness of the interview process. The participants felt that their privacy
and confidentiality were protected. They could freely discuss personal experiences
on sensitive issues such as the influence of culture on behavior and on their
personal relationship with their spouse and family members.

Figure 23: Age distribution
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Variable

N (%)

Marital status
Married
Single/divorced/widow
Gravity
Multi
Nulli
Education
No formal education
Formal education
Occupation
Unemployed
Employed
Ethnicity
UAE national
Other Arab national
Religion
Muslim
Disease stage at presentation
IIB
III
Family history
Positive
Negative

14 (73.7)
5 (26.3)
17 (89.5)
2 (10.5)
5 (26.3)
14 (73.7)
8 (42)
11 (58)
12 (63)
7 (37)
19 (100)
10 (52.6)
9 (47.3)
3 (15.8)
16 (84.2)

Table 8: Socio-demographic characteristics of the study participants
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The interval between
symptom discovery
and diagnosis in
(months)

Association between the time interval
between symptom discovery and
diagnosis, %, age & stage
N (%)

9 (47.3)
3-5 months

6-10 months
11-12 months

1 (5.2)
2 (10.5)

13-18 months
19-24 months
More than 24 months

1 (5.2)
1 (5.2)
5 (26.3)

Age
40
36
65
55
45
47
60
36
36
45
40
67
48
60
68
50
55
36
36

St
age
IIB
IIB
III
IIB
III
IIB
IIB
IIB
III
III
III
III
IIB
III
III
III
III
IIB
III

Table 9: Extent of delay

The three main themes identified through thematic analysis process were
1) symptom recognition and appraisal, 2) role of community and social network
and 3) healthcare delivery system. These are presented with illustrative quotes in
the following sub-sections:
Symptom recognition
Visibility of symptom
Breast cancer symptoms vary from lumps to skin changes and nipple
bleeding. Despite the visibility and the classical presentation of breast cancer
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symptoms, five of the interviewed women interpreted the warning signs
incorrectly.
“Around two years ago…. I noticed a lump… like a small peanut…..I only felt it
when I touched my breast, I am not currently breastfeeding but I thought it was
something related to an old breast milk as I breast fed all my children, frozen old
milk or something….’’
Persistence of symptom
The persistence of the symptom was sometimes the reason to draw
the woman’s attention to the presence of disease, and this motivated them
to seek evaluation and treatment.
“I was breastfeeding and I noticed my breast is getting hard with a lump, I
thought it is from milk accumulation, I ignored it and continued breastfeeding for
a while ……but then the lump was not going away; my breast was getting larger
and larger every time I look……..only then I realized that something might be
going wrong with me ….’’
Risk perception
Women did not view themselves as at risk for breast cancer. They
did not have personal perceptions of susceptibility and education level did
not appear to influence their behavior in regards to measures for early
detection of breast cancer.
Interviewer: “Have you had mammography before?’’
“Never, never because I am ….years old and married, I have 5 children; I do not
take any medicine except the glucophage tablet for my diabetes……. I am very
very healthy, so I did not go for the screening….I mean why should I ?... I used to
do pap smear ……many times, I was concerned about cervical cancer but breast
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cancer…. never suspected it. I was telling myself why should I go for checking if I
am not feeling anything’’
Attribution
Women attributed signs of breast cancer to other diseases or to an event
that happened prior to the symptom discovery. One of the women interviewed
thought the breast lump was due to a fall she had prior to discovering it. This
attribution greatly contributed to long delay until a symptom of an advanced
disease appeared.
“Well… around a year and a half ago I noticed a lump in my breast… I was
thinking it is from a fall I had previously…. All the doctors were upset from me…
they were saying where have you been hiding with this huge bleeding breast, you
should have come earlier….I said to them I was treating myself by myself…..I
thought it was a trauma related symptoms…I was putting ointments and taking
pain killers to cope with it…’’
Misconceptions
Women had misconceptions about the breast cancer and its treatment.
“I was afraid from the surgery and the disease…. Previously we had a
misunderstanding that if you go for surgery the disease will get spread… because
they touch it…. This is lack of awareness… people used to refuse surgeries
because of this myth… I used to be thinking this way…. But thank God I did the
surgery”
“I heard that breast cancer comes after a certain age more than 50 years and it
does not come to women who breastfeed. But I had while I was breastfeeding, so I
realized it has nothing to do with breastfeeding”
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Symptom appraisal
Breast cancer knowledge
Four women did not know about the breast cancer relevant
symptoms and signs, screening procedures and treatment options.
’’ I heard of cancer before…blood cancer, brain cancer, lung cancer……. but I
never thought it can come in the breast…I was surprised when they informed me’’
“I felt the lump long time ago….around two years ago, I never expected it could
be cancer…. I was even going to my heart doctor frequently but never thought of
mentioning it to him, until I saw some blood coming out of my nipple, then I asked
him ”
“I didn’t complain of anything,….I didn’t even have pain…it was only that small
lump which never bothered me….”
“I never expected it, to be honest, because I was active…I worked two jobs…I
work outside…and at home, I like the house chores and…I mean…I was a home
body, like they say….I liked to work. So I was active and had no symptoms. I
didn't have pain, nor stinging or any…..let's say….symptoms regarding the
breasts. Not in the breasts or the nipples or excretion of fluids…I didn't have any
of those problems at all…”
Knowledge of health services
A lack of knowledge about healthcare services available for breast
cancer screening and treatment was verbalized by one woman interviewed.
‘’I was feeling my breasts regularly, I felt a small lump…but I did not know
where to go….. I asked my neighbor and she didn’t know as well….. She advised
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me to read holy Quran and apply olive oil to it…. I did that for a couple of
years….’’
Attitude regarding seeking help
A few (3) women thought that in order to have cancer, they had to
experience serious symptoms, such as pain, vomiting or bleeding. They did not
consider painless lumps to be a serious condition that would require immediate
attention.
‘’ I don’t go to the doctor to ask for unnecessary tests, you do not go to a doctor
if you are ok; you have to be in extreme pain or complaining of something to go
and see a doctor…..’’
“Around two years ago. It was from inside nothing was showing outside, I
thought it is something related to breast milk, frozen or something…”
“I was concerned about cervical cancer but breast cancer never suspected it. I
was telling myself why should I go for mammogram if I am not feeling anything, I
only suspected it when I felt I was losing weight and became pale…”
Community and social network
Breast cancer stigmatized
A woman expressed the difficulties with day to day activities and how she
experienced suffering and worry even before experiencing cancer. Many felt that
they fulfill multiple roles in regards to their families and to society. They felt
pressurized because they are expected to be role models in their society and
cancer is thought to affect this role and the attitude of society members to them
once they experience disease.
“Our old ladies used to say stress …. you know the relationships and troubles
which happen in life... all this stress is one of the contributing factors to cancer

100

especially in the middle east … because women in the middle east suffer in silence
over a lot of things … for example, I knew women who have family, who have
children … then the husband goes and he marries another woman.. She reaches
the depth of despair that my husband is married to another woman... the husband
comes home for one night... Do you see the children going astray, the boys are not
being controlled … they have no control because he has another family or two
families... The wives get stressed, they go crazy and they end up with some form of
illness and usually breast cancer, this is what I have actually observed ….’’
The women expressed concerns about stigma and prejudice
towards the whole family because of such a disease as breast cancer.
Women with breast cancer therefore often prefer to stay at home and
suffer in silence because they do not want their families to pay the price of
having a mother, a sister, or an aunt with breast cancer.
“When there is a family history of breast cancer, the older women keep it quiet
the whole family keep it quiet because we are worried about our daughters
prospects for getting married... we are worried about our younger sisters getting
married, and we are worried about getting a bad name in our family or people
staying away from us … because people are afraid of ‘-catching-’ the disease, we
keep quiet and we do not say that we have cancer through the generations of this
family … we are all afraid psychometrically to come forward and frightened to
come forward to say I have a lump .. Because we are worried about our image
and our families... we are worried if our husbands would still want us... we are
worried about whether we are still able to produce children…worries and
worries….. This is what makes us hide’’
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Silence around women’s issues
Most of the women shared the view that cancer was not a popular topic to
talk about in society or even within the family. It was not encouraged to talk about
cancer openly in society or even discuss it within the family. It is a sensitive topic
surrounded by shame and silence.
‘’Before I never heard of breast cancer not even cancer, nobody was allowed to
talk about it, you just look at their eyes and you will see the fear and
vagueness…you will just know...’’
Another aspect which emerged in the interviews is the way society views
breast cancer survivors. Members of UAE society do not want to talk about cancer
survivors, not because they are ashamed of them, but because of the inadvertent
bad publicity. Most of the participants disclosed that nobody around them knew
about their cancer diagnosis and they would prefer to keep quiet and not share this
news with anybody because they do not know how people around them would
react to the information. Others were convinced that they will be treated badly and
that their families will suffer with them as well.
“Because here in our culture people look to you differently if you have cancer, I
didn’t tell anybody….I did not want them to look at me this way…. My whole
family will be affected’’
Some were isolated from society because people do not want to visit them
as they are afraid of the evil eye (in Arabic culture the evil eye is a symbol for
envy and jealousy from a sick person regarding the health of a healthy person. this
is believed to bring bad luck and disease) or thinking the disease is contagious.
These misconceptions and a lack of general awareness about the nature and cause
of cancer made most of the women keep their disease hidden and some do not
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seek medical attention even when they have relevant signs or symptoms of breast
cancer.
“People will say do not visit auntie (me)…. she has cancer because you do not
want to catch it, the bad eye will fall on you do not go and visit her …’’
Another informant talked about a painful experience she had as a result of people
knowing what she was suffering from during her treatment.
“I just finished chemical therapy and I went to visit somebody in her house, she
had some other guest, four women. While sitting with them, my head cover moved
a little and some of the bald patches on my head were revealed. They looked at me
and laughed and started whispering to each other’s, I could not take it, I left
immediately and went home, I was crying all night long. I told my sisters that I did
not want to see that look from people and that’s why I isolated myself away from
them and since then I don’t visit anybody….’’
Some participants expressed the idea that the society considers them guilty and
having cancer is a payback for sins and mistakes during their life.
Informant (7): “My husband and family said to me….oh you must have done
something in your life and it came back on you…. what did you do? This is to pay
for your sins’’
Fear of being abandoned by husband
An informant talked about the relationship she had with her husband after
she was diagnosed and how he was living with her under the same roof but not as
a married couple.
“My husband completely changed, I have been married for 10 years; I was
diagnosed a few years ago and since then he was pretty much on his own. It is
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because of cancer….I suppose he tried to support me in whatever way he could...
But I would never let him see me down; I will never let him see that he broke me’’
Another woman talked about the intimate relationship between her and her
husband.
“The change was mainly sexually, we never sleep together after I was diagnosed,
we just live in the same house and we tolerate each other. I did the full breast
reconstruction and I was happy ….he wasn’t ….actually he never saw them….you
see the husbands supporting their wives in TV only, in romantic movies but not in
real life…this is the truth’’
Healthcare system
Acceptability
A woman delayed for 8 months because she did not want a male physician
to examine her. This religious and cultural restriction on contact between the
sexes contributed to the delay in seeking help.
“I felt a lump in my breast, I went to the health center in my village and they only
had one doctor… a male doctor…of course I went back home without checking
and I forgot about it… few years later… the breast cancer campaign came to our
village and I was diagnosed and referred to the hospital”
Diagnosis error
Two women experienced delays because of inaction by healthcare
providers. Errors in diagnosis can cause false reassurance regarding the
seriousness of breast symptoms or signs.
“I went to the hospital, they said there is nothing to worry about and the lump is
from milk production. So I did not check further, the tumor was smaller… Three
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years later, the tumor became very big, I went to another hospital and they said
you have cancer…’’
Referral process
Some delays were made by healthcare providers after diagnosis,
particularly in waiting to be referred to a regional oncology center for
commencement of treatment.
“I went at the beginning of the year and they did for me the x-ray which squeezes
the breast. They said I have cancer and that they will refer me to Tawam
Hospital… I waited for their call but nobody called me for 6 or 7 months…”
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Phase III (cross-sectional)
Statistical analysis
Results
A total of 305 eligible women were approached, of whom 247 women
agreed to participate and completed the research questionnaire in March, 2013
(response rate 81%). UAE nationals constituted 43.3% (107) and the remainders
were citizens of other Arab countries. The majority were married 88.7% (219) and
94.3% (233) were literate. Their mean age was (46.1) years ± SD 4.95. See Table
(11).

Category

247

Breast Self- Clinical
Mammography
Examination Breast
n (%)
n (%)
Examination
n (%)
127 (51.4)
122 (49.4)
111 (45.1)

107

56 (52.3)

59 (55.1)

53 (50%)

Non-UAE
national

140

71 (50.7)

63 (45)

58 (41.4)

40-49 yrs

200

101 (50.5)

95 (47.5)

81 (40.7)

≥50 yrs

47

26 (55.3)

27 (57.4)

30 (63.8)

No formal
education
(illiterate)
School level

14

8 (57.1)

9 (64.3)

11 (78.6)

115

55 (48.2)

58 (50.9)

52 (46)

College/university 118
level

64 (54.2)

54 (45.8)

47 (39.8)

Sub-category

Total
Nationality UAE national

Age

Education

Total
(n)

Table 11: Socio-demographic variables of women who attend breast cancer
screening (BSE, CBE, and mammography)

106

The screening uptake in our study group was BSE (51.4%), CBE (49.4%),
and Mammography (45.1%). In this study, 22% stated that they were not sure if
breast cancer was contagious, 38% believed that only women got breast cancer,
43% reported that breast cancer is the commonest type of cancer in women, and
26% believed that breastfeeding was protective against breast cancer. 17.5%
thought that mammogram was done only when having symptomatic breast
complaints. In our study, 16% of women were not sure when to go for
mammography. 5% had good general knowledge of breast cancer while 14.6%
had very poor knowledge of breast cancer. UAE national women scored better
than non-UAE national women (means 7.14-6.99) (See table 12). Generally,
younger women (40-49) years of age had better scores regarding knowledge than
older women (>49) years of age as expected. Level of education was positively
associated with better knowledge scores (p=<0.001).

Category
Nationality

Age group

Highest Level of
education

Sub-category

Frequency
n
(%)

UAE nationals

107 (43.3)

General
knowledge score
Mean (SD)
7.14 (2.87)

Non-UAE nationals

140 (56.7)

6.99 (3.29)

40-49

200 (81)

7.12 (3.18)

>49

47 (19)

6.78 (2.83)

No formal
education
School level

14 (5.6)

5.57 (2.53)

115 (46.5)

6.56 (2.97)

College or
University

118 (47.9)

7.71 (3.18)

Table 12: General Knowledge score by different variables
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To determine predictors of screening, multivariate logistic regression
analysis was performed (table 13). The predictors of BSE, CBE and
mammography are in table 3. Having higher knowledge score and being
counseled by a healthcare provider regarding breast health were the strongest
predictors of screening uptake. A negative association was noted between
screening uptake and nationality (non-UAE nationals), non-UAE nationals had
poorer mammography uptake compared to UAE nationals, but the association was
not significant (p=0.758). UAE- nationals reported being given breast health
counseling (52.8%) more than non-UAE nationals (47.2%) p=0.002. 85 (62.5%)
of women who reported not having had mammogram had never been given breast
health counseling (P=<0.001). Women who reported not regularly performing
BSE, CBE or Mammography were asked to choose a reason for that. Reasons
with women responses are outlined in table (14).

Variable/
predictor
Age
Education
School
level*
University
level*
Knowledge
score
Breast health
counseling

BSE

CBE

Mammogram

OR (95%CI)

P

OR (95%CI)

P

OR (95%CI)

P

0.96 (0.90-1.02)

0.241

0.94 (0.88-1.00)

0.062

1.14 (1.07-1.22)

0.001

2.59 (0.59-11.24)

0.204

2.61 (0.60-11.22)

0.196

0.18 (0.37-0.91)

0.039

1.79 (0.39-8.13)

0.448

3.52 (0.78-15.90)

0.101

0.13 (0.02-0.72)

0.019

0.81 (0.73-0.90)

0.001

0.83 (0.75-0.92)

0.001

1.20 (1.09-1.33)

0.001

4.30 (2.36-7.85)

0.001

3.95 (2.21-7.05)

0.001

0.38 (0.21-0.69)

0.001

*As compared to illiterate education group
Table 13: Predictors of Screening
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Screening method

BSE

Total
CBE

Total
Mammography

Reason

I would like to do it but I do
not know how
I know about it but I am afraid
to do it or have no time to do it
Never heard of it
Not for my age group
I know about it but I am afraid
to do it or have no time to do it
Never heard of it
Not for my age group
I know about it but I am afraid
to do it or have no time to do it
Never heard of it

Total

no.

Education
Illiterate School

University

33

Nationality
UAENon UAENational
National
n (%)
n (%)
12 (23.5)
21 (30.4)

n (%)
4 (66.7)

n (%)
20 (33.3)

n (%)
9 (16.7)

46

17 (33.3)

29 (42)

1 (16.7)

15 (25)

30 (55.6)

41
120
52
17

22 (43.1)
51 (42.5)
18 (36.7)
8 (16.3)

19 (27.5)
69 (57.5)
34 (44.7)
9 (11.8)

1 (16.7)
6 (5)
2 (40)
0 (0)

25 (41.7)
60 (50)
27 (47.4)
5 (8.8)

15 (27.8)
54 (45)
23 (36.5)
12 (19)

52
125
46

23 (46.9)
49 (39.2)
14 (25.9

33 (43.4)
76 (60.8)
32 (39)

3 (60)
5 (4)
2 (66.7)

25 (43.9)
57 (45.6)
21 (33.9)

28 (44.4)
63 (50.4)
23 (32.4)

30

14 (25.9)

16 (19.5)

0 (0)

13 (21)

17 (23.9)

60
136

26 (48.1)
54 (39.7)

34 (41.5)
82 (60.3)

1 (33.3)
3 (2.2)

28 (45.2)
62 (45.6)

31 (43.7)
71 (52.2)

Table 14: Reasons for not performing regular BSE, CBE, and mammography
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Chapter six
DISCUSSION

Phase I (descriptive)
The study analyzed 1,611 breast cancer cases registered at Tawam
Hospital cancer registry. The cases were diagnosed between 2008 and
2012. The sample does not represent the whole UAE, but it captures a
good proportion of breast cancer patients referred to Tawam Hospital.
Many data were missing as many patients are managed abroad. UAE
nationals were found to be 21.4% (344) of all cases. The majority of cases
34.1% (550) fell between the ages of 41-50 years old, and 61.3% (989)
were ≤ 50 years old. These results are similar to those derived from the
literature of neighboring countries.
The literature from developed countries indicated that breast
cancer risk increases with increased age at diagnosis (Fakhro et al., 1999).
However, the age at diagnosis of breast cancer in the Arab world was
reported to be a decade earlier than in western countries (Najjar and
Easson, 2010). In this study the average age at diagnosis was 48.1 years
old, which is similar to other countries in the region. This data suggest that
there may be clear social, economic and population differences in the age
of presentation of breast cancer between Arab and Western populations.
This also has important implications for screening and cancer management
strategies in these countries, including the ideal age at which to begin
screening. Adoption of Western guidelines without critical amendment in
planning breast cancer programs might waste resources without achieving
desired outcomes. Determination of the true frequency and age of onset of
breast cancer in Arab women should be an important research priority.
Moreover, the optimal screening modality would also need to be explored.
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Screening mammography is less sensitive in younger women, mainly due to
increased breast density that can obscure the radiological features of early breast
cancer. However, magnetic resonance imaging (MRI) has proved to clarify
ambiguous lesion on mammograms. In fact, strategies that combined MRI plus
mammography with or without ultrasound and clinical breast examination
reported sensitivities of 93-100% (Lord et al., 2007) and could be investigated in a
randomized fashion as a screening modality in young Arab women.
In 2008, Abu Dhabi Community Profile indicated that breast cancer
patients in UAE visit physicians in later stages of the disease. Our finding showed
53.4% of breast cancer cases had tumor size of ≥ 2cms, and 52% of cases had
tumor size 2-5 cm at presentation. This confirms the assumption that women
present with palpable breast lumps of ≥ 2cms. Only 12.2% were diagnosed at
stage 1A and 92% of cases had axillary lymph nodes involvement at diagnosis
with 8.3% of cases having distant metastasis. Larger tumors at presentation and
advanced stages with lymph nodes involvement and distant metastasis have
implications on treatment options available for Arab women. For example, breast
conserving surgery is generally appreciated by young patients, but with larger
tumors. Negative surgical margins might not be achievable and sometimes left
with the option of mastectomy. Because of this reason, rates of mastectomy are
high in the Arab countries (refer to table 4). Mastectomy is a source of anxiety
and fear for many women. This fear might act as a barrier for screening and early
detection. Aggressive chemotherapy with all its side effects and complications is
often necessary. Treatments need to follow standard protocols to avoid
inappropriate management and non-compliance. Reconstructive breast service
should be offered to all women. A comprehensive plan that includes training in
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the different disciplines is required for healthcare providers to recommend
screening for younger women and not to dismiss the suspicion of
malignancy in younger women. The establishment of specialized breast
units, provision of equipment’s and adequate financial support is required
to care for these patients properly.
A delay of more than 3 months was closely associated with
increased tumor size and advancement in the disease stages (Kothari &
Fentiman, 2003). Rossi et al. (1990) found a consistent and direct
relationship between delay and tumor size, nodal involvement, presence of
metastases, and histologic grade of disease at diagnosis. The 5-years
survival of women who had surgical treatment after a total delay of less
than two weeks was 90% compared with 80% of those who had a total
delay of more than two weeks and this effect of delay on survival was
observed to be significant in younger women (15-39 years old) (Smith et
al., 2013). In our study a delay of more than 3 months between initial
diagnosis and first course of treatment had significantly decreased survival
time (p=0.039). This delay was calculated as the difference between the
initial diagnosis and the start of first course of treatment. In this case, it
was not known whether the delay was from the patient after receiving the
initial diagnosis or from healthcare providers/system if referral or
commencement of treatment consumed time more than 3 months.

113

Phase II (qualitative)
Lack of knowledge and risk perception
Knowledge and perception of breast cancer contributes to women’s
participation in screening activities (Amin et al., 2009). A woman needs to know
all relevant information about breast cancer including risk factors, signs, personal
and population risk and who is most affected and why before attempting to make
a decision whether to seek medical advice or not. The lack of this knowledge may
contribute to the delay. As illustrated in the health seeking model, after the
discovery of the symptom, the woman has an internal dialogue trying to evaluate
the seriousness of this symptom, and without the knowledge and perception of
risk, the decision might not be favorable. In this study, the demonstrated lack of
knowledge of breast cancer reported by the study participants was translated by
the low adherence to breast cancer screening guidelines. In this study, participants
verbalized their feeling that breast cancer did not impose a serious threat prior to
being diagnosed with it. This misunderstanding may reflect the prioritization of
breast cancer screening. The screening concept itself is strange, and
mammography is not socially accepted in the community (Baron-Epel, 2010).
Cognitive factors play a major role in the perception of risk and prevention
behaviors (Noroozi & Tahmasebi, 2011). Champion (1999) as cited in (Noroozi &
Tahmasebi, 2011), modified the Health Believe Model in an attempt to understand
women’s beliefs and perception of risk with regard to CBE and mammography.
Champion (1993) suggested that preventive health behaviors are based on four
factors: (a) susceptibility: perceived personal vulnerability to or subjective risk of
a health condition, (b) seriousness: perceived personal harm of the condition, (c)
benefits: perceived positive attributes of an action, and (d) barriers: perceived
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negative aspects of an action. These four factors define the women’s attitude
toward health prevention actions and prioritization in her life. Health motivation
and self-efficacy were then found to be influential in the health prevention
behavior.
The role of healthcare providers
The healthcare providers’ role in increasing the awareness of these
symptoms and encouraging women with such symptoms to seek clinical
help is an important activity. Not perceiving painless breast lumps as a
threat to life and therefore delaying seeking help reflects the lack of
knowledge in regards to breast cancer. Despite the advancement in breast
cancer treatment, the establishment of screening services in the emirate of
Abu Dhabi, and the availability of health coverage, there is still a
considerable lack of awareness about breast health, regular screening, and
breast cancer signs/symptoms and predisposing factors (Bener at al., 2001;
Taher et al., 2008). Public health education has a strong impact on
women’s perception and knowledge of breast cancer (Johnson & DicksonSwift, 2008). Earlier studies have reported that physicians’
recommendations were the single strongest predicator of breast cancer
screening (Friedman et al., 1999; Thomas & Fick, 1995). Participants in
this study reported the lack of advanced directions from healthcare
providers, especially physicians. Neither the participants have been
referred by a healthcare provider for breast cancer screening, nor did they
receive recommendation or information on breast cancer screening
guidelines. Even after diagnosis, many participants verbalized the
uncertainty and lack of confidence about their level of breast cancer
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knowledge. Some participants, who lost their breast after surgical treatment, did
not know what they should do after treatment finished and whether they should
follow any screening guidelines for the remaining breast.
The participants in this study verbalized their awareness about where to
get information about breast cancer if they wanted, but the way this information
was presented was not appealing to them. They also discussed the complexity of
the data presented to them in an overwhelming and confusing manner. A number
of women were not aware about the breast health services and programs offered to
them and their cost. Female nurses play a major role in the productivity of public
health education programs, especially in a culturally gender sensitive community
(Hussain & Ansari, 1996). Many studies in the Middle East have been conducted
to measure the knowledge level of healthcare providers about breast cancer and
screening guidelines, and some of them concluded that the inadequate knowledge
(Alkhasoneh, 2007; Jaradeen, 2010). In this study, many participants did not have
trust in the healthcare professionals and they sought advice from different sources
for the symptoms they experienced, including friends and family members. Other
participants did not want to consult a healthcare provider because they believed
they should only see a physician when the symptom is serious, such as feeling
pain, bleeding, or experiencing fatigue. Screening was a novel concept in this
community. Although painless lump is the most common presenting symptom of
breast cancer, many participants in this study believed that a painless lump does
not qualify for a doctor visit. This might be related to the weak relationship
between women and their healthcare providers. There is a need to assess the
counseling practices offered to women by their healthcare providers.
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Muslims’ and Arabs’ lifestyles are based on the traditional Islamic
value system detailed in the Holy Quran and exemplified in the lifestyle of
Prophet Muhammad (Peace Be Upon Him). Due to the diverse population
in the UAE, many healthcare workers are of non-Arab and Non-Muslim
origin. Unintentionally, this might lead to violation of customs and beliefs
which can prevent the establishment of relationship that allow health care
providers to explore different issues related to the Arabic and Islamic
culture. Cultural competence is an important concept when attempting to
resolve obstacles in this relationship. Hammoud et al (2005) suggested
two levels of cultural competence. The first level involves the basic
understanding of certain beliefs and customs that can greatly influence the
lives of patients within certain cultures. This opens doors to relationship
with patients in an attempt to proceed to the next level which is the
exploration of individual concepts of health and illness. Another obstacle
faced by women in the UAE is the language barrier. As many healthcare
providers do not speak Arabic, this might be an issue when administering
public health education. Cultural and language barriers may keep Arab
women from seeking healthcare or cancer related services.
Healthcare provider gender is a very important factor in attracting
women to participate in screening activities and in presenting earlier for
treatment. Arabic and Muslim women prefer female healthcare providers.
Muslim women might refuse treatment no matter how urgent is the
situation if the provider is a male (Hammoud et al., 2005). In this study, a
participant delayed seeking medical help for eight months because of the
unavailability of a female healthcare provider at the nearby health center.
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The current public health program is deficient either in communication important
health messages or in reaching enough women.
Cultural, religious and societal influences
“A culture is a configuration of learned behaviors and results of behavior
whose component elements are shared and transmitted by the members of a
particular society” (Linton, 1945, p. 32). There are three major socialization
blocks in Arab/Muslim culture that could impact the delivery of healthcare
significantly. These are the family system, the role of the individual relative to
social organization and the assignment of primary gender roles (Hammoud et al.,
2005). The family system in the Arab world is considered one of the strongest.
The oldest male of the family is considered the guardian. All issues in the family
need his approval. In this study, conducting interviews with the participants
needed the approval from the head of the family. Most rejections to the women
participating were due to the disapproval by the head of the family. The interview
venue was then changed to the non-threatening environment of the hospital as it
was thought to be more convenient for the participants to freely discuss their
experiences. The traditional role of women in Arabic and Islamic culture is an
important factor in the help seeking process. The pervasive societal expectations
of the community are high. Women are seen as caregivers, obedient and role
models for their daughters and younger female members of the family. The Arab
tradition emphasizes that collective welfare outweighs individual wellbeing.
Women’s traditional role allows them to think of their own needs only after
considering all other family members’ needs. Some women suggested feeling
inferior to men in the community and being less powerful, as their role in the
family obliges them to please their husbands and obey them.
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Like other studies (Baron-Epel, 2004; Remmenick, 2006), this
study found that fear of losing this traditional role was found to be a
barrier for early presentation with breast cancer symptom. Fear about the
community’s reaction in regards to women with breast cancer, and failing
to meet community expectations about health and disease strongly
influence the decision making process more than the fear of death from
impending disease (Azaiza & Cohen, 2008). Many participants in this
study preferred to keep their disease as a secret; they did not want their
surrounding community to talk about them. Therefore this fear holds the
women back from seeking medical advice and imposes silence.
Abuidris et al. (2013) discussed social stigma surrounding breast
cancer. This might be due to the fact that the breast is attached to the
sexual and reproductive system. In Islamic culture, women are inhibited
from asking questions about physical and related changes. Women were
raised to understand that part of being a grownup woman is to keep silent
about women’s health issues (Hamid et al., 2010). Women prefer to hide
the disease from their families and friends, trying to escape accusations
and the feeling of guilt and shame. In our study, most participants
preferred to keep their disease hidden. One participant’s family and
husband accused her of committing major sins in her life and that was why
God was punishing her with breast cancer.
The religion of Islam shapes Muslims’ lives. It defines different
aspects such as marriage, relationships, health and illness and death.
Healthcare providers could be confronted by the theme of faith or destiny
“Qader” in Islamic culture. Muslims consider this belief a defining idea
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about events which are beyond the individual control. Muslims believe that no
matter what you do, everything in your life is defined and written and no one or
any action can change it. From a non-Muslims healthcare providers’ perspective,
Qader is considered fatalistic. In this study, many participants believed that
having breast cancer was their destiny “Qader” and it does not matter if they knew
or practiced screening, their Qader would not have changed. This belief puts
additional pressure on healthcare providers on designing and providing focused
education programs that carefully incorporate religious messages in an attempt to
persuade women to participate in breast cancer screening activities. This study
shows that cultural and societal beliefs have a great effect on women’s attitudes
and behaviors towards symptom recognition, appraisal, screening and presentation
for medical treatment.
Traditional Islamic medicine
Traditional Islamic medicine originates from the life of Prophet
Muhammad (Peace Be Upon Him). Many Muslims may employ “prophetic
medicine” as part of their normal life and disease cure. Prophet Muhammad’s
lifestyle and recommendations were used as a basis for the prophetic, recorded in
the hadith (reports) and certain verses of the Qur’an. Pork, alcohol, and other
intoxicants are prohibited and the regular consumption of fruits and vegetables,
dates, yogurt and milk is encouraged with emphasis on the avoidance of
overeating. These are the main aspects of this prophetic medicine. The use of
honey, olive oil and black seed (nigella sativa) products are particularly
widespread as preventative medicines and treatments for a variety of diseases
including cancer. Other healing methods are cautery and hijama (pressure cups to
remove spoiled blood). Many participants in this study verbalized using one of
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these methods, most commonly herbal drinks of black seed and honey. One
participant reported the use of camel milk and urine for curing cancer and others
discussed the use of cautery in the treatment of gastrointestinal cancers. Most
participants believed in traditional Islamic medicine but preferred to inform their
oncologists before using it.
Another well-known concept in traditional Islamic medicine is the “evil
eye”. The evil eye is believed to be the jealous look of others upon the good
fortune of another without saying “Mashaa allah” or God’s will to prevent it from
harming another. The evil eye may initiate an adverse event for another, including
harm to their health, business or family. All Muslims follow the assumption that
God is the ultimate healer, the divine word, expressed in the Qur’an, has the
power to heal the body, mind, and soul, many Muslims recite the Qur’an over the
site of pain, offering special petitions, and exorcism of evil jinn. All participants
in this study employed spiritual remedies to heal their disease, mainly by reciting
Qur’an or visiting Mutawaa “Islamic leader” to recite the Qur’an on them.
Role of spouse
The husband’s relationship with a woman diagnosed with breast cancer is
a very sensitive issue. This study provided an opportunity for women with breast
cancer to openly talk about their feelings, behavior and relationships. In Islamic
religion and culture, men are allowed more than one wife, and this fact puts fear
and pressure from being disfigured by surgery and losing a husband and support
for their children.
Dahlui et al. (2013) reported that marriage was a predictor of regular
practice of BSE, CBE & mammogram. They also reported that women who had
supportive husbands are nearly two times more likely to attend CBE and more
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likely to perform BSE. In this study, none of the participants reported the
attendance or support of their spouse during diagnosis or treatment. Two
participants reported being abandoned by their husbands after diagnosis. Women
with supportive husband and families tend to be diagnosed at an earlier stage. In
this study, some participants discussed the role of their husband in their lives after
diagnosis. Some reported their spouses being better at being instrumentally
supportive than emotionally so. Similar to the findings of Fergus and Grey (2009),
a major challenge faced by women is the altered sexuality caused by the stress of
the illness and side effects of treatment. Participants revealed their struggle with
how to retain intimacy and feelings of closeness without their usual sexual
routines. Including husbands in the education programs and encouraging them to
attend with their wives the CBE and mammography is essential for successful
breast cancer screening promotion (Osborne et al., 2005; Umberson, 1992).
Phase III (cross-sectional)
Our results are consistent with those of a Saudi Arabian study (Amin et
al., 2009) in which screening services were noted to be underutilized and mainly
used for the diagnosis or follow up of existing breast lesions. Screening services
are widely available in the UAE, with the advantage of screening coverage by
health insurance and availability of free screening offered by some facilities for
non-nationals with limited coverage from health insurance. Unfortunately, women
are not referred for screening in these facilities. In this study, 81%, 41.3% and
82.6% of women who practiced BSE, CBE and mammography respectively stated
that it was recommended by their healthcare provider. In general, Arab women
regard physicians’ offices, clinics and other healthcare facilities as places to go
only when one feels ill or when symptoms appear. Moreover, 37.9% of women
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gained their breast cancer knowledge from their healthcare provider. 18.2% of
women believed that a mammogram is only done when preceded with a serious
breast complaint such as pain or inflammation. Consequently this perception can
serve as a barrier for health promotion efforts to achieve high participation rate.
This has implications on the effectiveness and success of current screening
programs. Our findings showed a significant improvement in the screening
uptake, BSE (51.4%), CBE (49.4), Mammography (45.1%) of women in the city
of Al Ain compared with findings of a similar study conducted in (2001) by Bener
et al., in Al Ain city, which showed uptake of (12.7%), (13.8%), (10.3%) for
BSE,CBE and mammography, respectively. Even in Qatari women (Bener et al.,
2009), the screening uptake was lower compared to our findings, 24.9%, 23.3%
and 22.5% for BSE, CBE and mammography, respectively. In the general uptake
of screening (CBE and/ or mammography), a study of Saudi women (Radi, 2013)
reported screening uptake of 20.5% compared to 58% in this study. One of the
major barriers to screening is the lack of knowledge about the benefits of early
detection (Pearlman et al., 2008). Studies have also implied that with improved
knowledge, screening uptake will increase (Fletcher at al., 1993; Davis et al.,
1996). In our study, responses to the general breast cancer knowledge questions
suggested inadequate knowledge. This finding supports previous study findings
(Bener et al., 2001).
Breast Self-Examination (BSE)
In this study, 51.4% reported practicing BSE. BSE was practiced among
UAE nationals more frequently than non-UAE nationals, at 55.1% and 45%
respectively. In contrast to the study conducted previously (Bener et al., 2001),
older women (≥49 years of age) were found to practice BSE more frequently than

123

younger age group (40-49 years of age). In our study, 81.6% of women practicing
BSE were given instructions by a healthcare provider compared to 38% in the
previous study (Bener at al., 2001). This might be due to the increased early
detection and awareness activities conducted by the local health authorities during
the past decade (Taher et al., 2008). Thus, offering information to women on how
to perform BSE improves screening practices (Smith et al., 2010). In the 1980s in
the United Kingdom it was found that after introducing the national screening
program, rates of advanced breast cancer reduced dramatically (Stockton et al.,
1997). In the UAE, the efforts of Abu Dhabi Health Authority are improving and
resources are directed toward better implementation of screening activities. The
improved rate of BSE practice in this study population indicates the success of the
educational and awareness programs. However, still the rates are low compared to
developed countries. In a total of 120 women who do not regularly perform BSE,
41 (34.1%) of them had never heard of BSE, and 33 (27.5%) expressed
willingness and interest to perform BSE if they were instructed on how to perform
it. However, 46 (38.3%) claimed good knowledge of BSE performance but not
actually performing it due to fear of discovering a lump or lack of time. See table
(14).
Clinical Breast Exam (CBE) and/or Mammography
In this study, 58% reported having a history of CBE or a mammography in
the past few years. This percentage is low compared to the other countries, for
example 72% of the target population in Canada reported to have had a
mammogram in the past two years (Statistics Canada, 2009). In the UK more than
80% of women aged 50-69 are reported to have had mammography in the
previous three years (WHO, 2008). However, comparing the UAE experience to a
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neighboring country, Qatari women reported low participation rate in breast
cancer screening activities, 23.3% and 22.5% for CBE and Mammography
respectively despite having adequate levels of knowledge level (Bener et al.,
2009). Our findings showed that 80% and 83% of women who reported having a
history of CBE and/or Mammography respectively indicated that these screening
techniques were recommended by their healthcare provider. Improvement in the
uptake of CBE has been linked to the increased awareness about the importance
of attending regular CBE (Dundar et al., 2006). Education level in our study was
positively correlated with knowledge score, however, participation in
mammography was negatively associated with education level, OR 0.18 and 0.13
for school level and university level respectively compared to illiterate women.
Although the level of knowledge of breast cancer was higher in more educated
women, they were not very keen on practicing mammography. 23 (32.4%) of
women who hold a university degree and do not perform regular mammography
believed that it is not for their age group. 56 (44.8%) of women who never had
conducted CBE and 60 (44.1%) of women who never had mammography
expressed lack of knowledge about existence of these screening techniques.
Healthcare providers play an important role as enablers and facilitators for
effective utilization of screening techniques. Not receiving a recommendation by
healthcare provider to perform screening has been found to be a barrier for
participation in screening (Azaiza & Cohen, 2006). In this study, some women
who never had CBE or mammography had a misunderstanding that they were not
in the target group for screening and they believed it is for older women (41.6%
and 33.8% in CBE and mammography respectively). In this study, older women
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(≥49 years of age) were more likely to go for mammography p=<0.001 (OR 1.14,
CI 1.07-1.22).
Another misconception noted was the belief that mammography should be
performed once and not on a regular bi-annual basis. It is also worth noting that
the quality of reassurance by the physician who tells the patient that there is no
significant finding may have a certain impact on the extent of concern retained by
the rescreened women. In fact, a benefit of breast screening programs and high
participation rates may be derived from reassurance for those women in whom no
evidence of breast cancer is found.
Breast lump interpretation
A question in the general knowledge section of the questionnaire was
introduced regarding the breast lump finding interpretation. Women were asked if
they would seek medical attention if they noticed a lump in their breast. Nearly a
third of the women interpreted the breast lump incorrectly and expressed less
worries about the nature of the lump and indicated no intention to seek medical
attention as they perceived the lump would be due to normal hormonal changes
which affects women at menopausal age or is related to breastfeeding. Correct
interpretation of the finding of a breast lump was positively associated with extent
of general knowledge p=<0.001 (OR 1.26 CI 1.12-1.41). Women easily fall in
misconceptions and myths about breast lumps. This study results highlight the
importance of misconceptions about breast lumps in contributing to longer delay.
56.9% of respondents misunderstood screening as seeking medical attention only
when symptomatic. Common barriers towards screening included fear of pain and
embarrassment fear of radiation causing cancer, and perceived inadequate
facilities. Women would change their minds if they became symptomatic or if
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their doctors, family or friends encouraged them. Holding a misconception about
breast lumps was strongly associated with prolonged patient delay. Increased level
of knowledge was present in women who did not interpret breast lump as
threatening or an alarming sign of breast cancer.

Screening and over-diagnosis
Multiple cancer screening tests have been advocated for the general
population. However, clinicians and patients are not always well-informed of
screening burdens. The ability of mammography to diagnose small, early stage
breast cancers, which have favorable prognosis, is well documented (MoodyAyers et al., 2000). Over-diagnosis or over-detection is a term used when a
mammogram detects cancer that would have neither caused death nor presented
clinically during the woman’s lifetime (Welch & Black, 2010). Although survival
is better in screened versus non-screened women, a number of biases may explain
this finding. According to the National Cancer Institute (2013) at least four biases
need to be considered when interpreting mammography screening benefits:
“Lead-time bias: Survival time for a cancer found mammographically includes
the time between detection and the time when the cancer would have been
detected because of clinical symptoms, but this time is not included in the
survival time of cancers found because of symptoms”.

“Length bias: Mammography detects a cancer while it is preclinical, and
preclinical durations vary. Cancers with longer preclinical durations are, by
definition, present during more opportunities for discovery and therefore are
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more likely to be detected by screening; these cancers tend to be slow growing
and to have better prognoses, irrespective of screening”.

“Over diagnosis bias: An extreme form of length bias; screening may find
cancers that are very slow growing and would never have become manifest
clinically in the woman’s lifetime”.

“Healthy volunteer bias: The screened population may be the healthiest and/or
the most health-conscious women in the general population”.

Recently, many scientists debated the benefits of screening and the issue
of over diagnosis and subsequent overtreatment. The reduced breast cancer related
mortality attributable to screening was balanced against the cost of screening in
terms of physical and psychological harm to women and the financial impact on
health services. An expert panel review of the value of breast cancer screening in
the UK published in 2012 (Independent UK Panel on Breast Cancer Screening,
2012) reported some limitations related to the available evidence. The panel
estimated that almost a fifth of breast cancers discovered through screening
resembles over-diagnoses. However, the report provided evidence of a 20%
relative reduction in deaths from breast cancer in women invited for breast cancer
screening. On the other hand, Baum (2013) criticized the UK panel review. He
claimed that the report lacked quality of life considerations. Because the clinical
trials used in the UK panel review were unable to detect any impact on all-cause
mortality, only cause-specific mortality was measured. Burton et al (2012)
suggested that with the advances in the systemic treatment of breast cancer
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(chemotherapy and hormonal therapy), the window for the impact of screening
narrows substantially and as over-diagnosis rates increase then the importance of
the relatively rare lethal toxicities of treatment increase. Baum (2013) also
indicated that any estimates of benefits and harms based on trials reported 20 to
25 years ago, as described in the UK panel review report, are irrelevant to the
modern practice of medicine.
There are analyses to other cancer screening programs. For example, the
value and effectiveness of prostate cancer screening has been debated recently.
The uptake of routine Prostate Specific Antigen (PSA) testing in the UK is not
high, although the incidence of prostate cancer has increased by 4% per annum
especially in the 1990s (Melia et al., 2004). There are conflicting opinions
regarding the magnitude of the screening benefit in different populations, the
extent of over-diagnosis and over-treatment of low risk disease, the optimum
treatment for localized disease and the costs of implementing procedures (Lane et
al., 2010). Pashayan et al. (2009) indicated potential stage migration of prostate
cancer if screening was introduced in the UK. The potential over-diagnosis was
modeled to be around 20% (Pashayan et al., 2009).
Over-diagnosis is of particular concern in lung cancer screening also,
because new imaging technologies can detect very small lung nodules. Although
these nodules are considered to be abnormal, their clinical significance remains
uncertain. Furthermore, persons most likely to be screened for lung cancer (i.g.,
heavy or long-term cigarette smokers) often have clinically significant cardiac or
pulmonary comorbid conditions, which increases the risk of serious adverse
events, including death, during diagnostic evaluation and treatment. Identification
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of over-diagnosed cancers through screening would unnecessarily put these
persons at potentially serious risk (Marcus et al., 2006).
In a multimodal cancer screening program, Croswell et al. (2009)
determined the cumulative risk for an individual of a false-positive screening
result and the resulting risk of a diagnostic procedure. They analyzed data from an
ongoing cancer screening trial. Four cancers were screened for: Prostate, Lung,
Colorectal, and Ovarian (PLCO). Fourteen screening examinations for each sex
were possible during the 3-year screening period. They concluded that “for an
individual in a multimodal cancer screening trial, the risk of a false-positive
finding was about 50% or greater by the 14th test. Physicians should educate
patients about the likelihood of false positives and resulting diagnostic
interventions when counseling about cancer screening” (Croswell et al., 2009).
Screening for breast cancer and prostate cancer appears to detect more
cancers that are potentially clinically insignificant (Esserman et al., 2009).
Esophagus and ductal carcinoma of the breast are examples for which the
detection and removal of lesions have not led to lower incidence of invasive
cancer. In contrast, colon and cervical cancer are examples of effective screening
programs in which early detection and removal of precancerous lesions have
reduced incidence as well as late-stage disease (Howlader et al., 2012 as cited in
Esserman et al., 2013) (See table 15).
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Table 10: Change in Incidence and Mortality of Cancers over Time from 1975 to
2010 as Reported in Surveillance, Epidemiology and End Results (Howlader et
al., 2012 as cited in Esserman et al., 2013)
However, recommendations for breast cancer screening have not changed
in any major way. The UK panel review stated that “The Panel agrees that overdiagnosis is important but it is impossible to say, for an individual woman with
cancer detected at screening, if her cancer represents over-diagnosis. It is therefore
difficult to estimate the magnitude of over-diagnosis”. Breast cancer screening
may yield individual level benefits, however community long term mortality
benefits still need to be investigated.
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Strengths and limitations
Similar to many studies of breast cancer with methodological limitations,
this study encountered some limitations which need to be considered in the
interpretation of results.
Phase I (descriptive)
Obtaining breast cancer statistics data for the first phase from the cancer
registry posed some difficulties as much assurance needed to be given before the
release of data. This could be due to the nature of study as it is the first study
based on cancer registry data in UAE describing breast cancer. Five years’ data
were available for analysis, however, breast cancer is a cancer that has relatively
longer survival rate than other types of cancer, and therefore 10 years’ data would
give a clearer analysis of survival. Heavy data censoring was faced as the data on
vital status was not complete. The cancer registry data obtained does not represent
all of the UAE. The data included many missing values and incomplete
information.
Phase II (qualitative)
This is one of the few qualitative studies on breast cancer in the Middle
East and describes the reasons for delay in seeking treatment. It explores different
aspects of the complex health seeking behavior of UAE national and non-national
Arab women in the religiously dominated society of the UAE. It will pave the
way for comparisons with the experience in other countries in the Middle East
(eg., Saudi Arabia) and other Muslim countries in Asia (eg., Malaysia). The
interdisciplinary nature of the research team allowed for different perspective
analysis.
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Breast cancer delay is a new topic of research in the UAE, there was lack
of prior research studies in the Middle East to compare to or build upon for this
topic. No developed model or framework for breast cancer help seeking behavior
was developed for Arab women. It is possible that, unknowingly, the investigator
recruited only women who were more open and willing to talk about their feelings
about breast cancer. The study was faced with some rejection from participants
regarding the interviews despite giving assurances that their identity will not be
disclosed by the research team and only group data will be published without
identifiers. This might be due to the complex nature of the study and the
sensitivity of the issues discussed. The interview venue needed to be changed so
participants could find it more convenient and less threatening to discuss their
illness experience. Caution in interpreting the findings regarding these women is
required since this was a small sample designed for a qualitative pilot study and
might not be representative of the greater target population. Further verification of
these findings may be derived through focus group discussions.
Trustworthiness in phase II/ qualitative study
During data collection, participants were visited several times in the
hospital before, during and after conducting the interviews to establish a good
rapport and to allow women to have sufficient confidence in the principal
investigator and the interview method to completely discuss their experiences.
Some interviews were conducted more than once to allow for more productive
discussion and to ensure that what was said by the woman was well understood by
the principal researcher. A second quality control check was to use coding of three
randomly selected sets of interview information, to be coded separately by a
different researcher with extensive experience with women issues and qualitative
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research methodology. The second researcher was not involved in the data
collection. It was reassuring to note that the codes generated by both researchers
were similar. All findings were brought back to participants for verification.
Phase III (cross-sectional)
This cross sectional survey is one of the few community based studies on
the effect of national screening program and knowledge and practice of breast
cancer screening among women in Al Ain city. We used a previously validated
questionnaire (CAM 2008). Mammography use and BSE performance were
evaluated with self-report, whereas mammography use can be more valid via a
medical record review. Overall, community-based programs should be expanded
to different women groups to assess the actual rate of screening behaviors and
effective factors on them.
Community centers were chosen as they would be more representative of
Al Ain community in comparison to recruiting women from primary health
centers as in previous studies. The study had sufficient power but faced some
limitations. Including time and resources constraints, it was not feasible to select a
random sample of women in the Al Ain community. A random sample could be
drawn from different households selected randomly. This might have led to sociodemographic differences between the two groups (UAE nationals & nonnationals). Multi-variate logistic regression analysis was therefore used to adjust
for these differences. Since this study was not completely based on a random
sample, the findings of this study may not be generalized to all women in the
UAE. Three types of bias might have been introduced as a result of non-random
sampling: (1) selection bias, (2) non response bias and (3) response bias. Selection
bias is a systematic tendency to exclude one participant or another from the

134

sample. In this study, the inability to select a random sample from Al Ain
community may have introduced selection bias. Moreover, women attending the
community cultural and religious center might differ from those in the
community. Not all women can attend these centers due to work or life
constraints. Non response bias might also be exemplified in this study with the
assumption that non respondent women to the questionnaire might differ from
women who were willing to respond. In this study, the response rate was 81%
which is considered high and has minimized the non-response bias. Source of
response bias could be generated by the interviewer who administered the
questionnaire, respondents can easily be lead to hide the truth, by interviewer
attitudes, the precise wording of questions, or even position of one question with
another. To minimize respondents’ bias, the principal investigator administered
the questionnaires.
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Chapter seven
CONCLUSION

Findings from this study confirm the occurrence of breast cancer in
younger age groups than in Western countries. It is still the most common type of
cancer occurring among females in the UAE. The analysis supports the
established guidelines of BSE and CBE but argues the mammography guidelines
in the UAE. Although Tawam Hospital cancer registry has gone through major
improvement in the terms of data collection and assessment during the past few
years, there is still large number of incomplete data of cases counted. For
example, hormonal receptors status, treatment, mortality/survival are all
incompletely assessed. In future years, breast cancer follow-up will be longer
allowing survival to be estimated with greater precision and to allow the
estimation of survival beyond the 5 years possible in the future.
The study suggests that delay in help seeking has had several
negative effects on disease prognosis. Culture has a great impact on the
decision making of affected women to seek help earlier. The lack of
awareness about signs and symptoms of breast cancer and routine
screening has affected symptom appraisal and consequently correct
decision making. Part of this study used a qualitative approach and
proposed a help seeking model to explain Arab women help seeking
behavior. Arab women in the UAE are surrounded by many influencing
factors in regards to their social environment, religion and culture which
often place them in a disadvantaged position with inequity in healthcare
access and illness. This study provides an understanding of women’s help
seeking behavior and factors influencing the time interval between
presentation of symptoms and signs to treatment. It reveals cultural and
religious aspects of breast cancer and the distinct way UAE society reacts
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with women who have breast cancer. Lack of knowledge was not the only reason
for delay; a complex array of personal, social, and cultural factors appears to
influence a woman’s decision on how soon to ask for appropriate clinical advice.
National efforts are needed to address specific benefits of early detection
and increase the awareness about these benefits. The establishment of a supportive
relationship between healthcare providers and women with an expectation of
periodic breast screening may reduce the likelihood for delay. Despite the increase
in the uptake of screening modalities in our study group, lack of knowledge about
breast cancer screening is still evident in this part of the UAE. The positive
association between knowledge of breast cancer and screening uptake is clear, but
it is always difficult to determine whether breast cancer knowledge preceded
cancer screening or whether previous exposure to screening increased knowledge.
A follow up case control study may help establish the direction of causality. Most
efforts of local health authorities were targeting individual level barriers of
screening; more holistic approach to tackle socioeconomic, cultural, and religious
factors is needed. Health promotion priorities should be aimed at clarifying
misconceptions and addressing barriers such as fear and embarrassment. In
particular, it should be emphasized that screening should be performed even when
asymptomatic. More awareness should also be raised towards available subsidies
and facilities. Opportunistic screening adopted by the national screening program
in the UAE does not completely fulfill the program objectives, so efforts need to
be directed toward organized and better utilization of resources. Language and
trust barriers between women and healthcare providers need to be minimized for
practical and efficient implementation of screening programs. There is an urgent
need for coordinated awareness campaigns organized by the local health authority
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and healthcare providers. Differences in the provision of breast cancer screening
services offered to women in the UAE are thought to be an outcome of the
fragmented health system of the UAE. The different health administration
authorities often allow for inequities in regards to access level and quality of
healthcare and preventive services. Information on breast health from different
health providers varies markedly, especially with regard to the screening
guidelines. The fragmented healthcare system in the UAE, which involves the
unorganized efforts from local health authorities, is a major barrier for the
consistency and continuity of breast health awareness and screening programs.
Health education is only intense during October, leading to a dramatic increase in
the number of mammograms in this month only and dropping to lower levels for
the rest of the year. Community outreach programs are deficient, especially for
women living in the urban areas. Healthcare professionals lack awareness of
screening guidelines and existing screening providers. Despite the wide
availability of mammography, Screening is mainly provided by the public sector.
Most private health care providers offer mainly diagnostic mammograms.
Communication and co working between providers in Abu Dhabi is not optimal
leading to missed opportunities for joint initiatives.
This study recommends that the mammography screening guidelines be
revised for consideration of younger age presentation with breast cancer. Starting
the clinical screening at the age of 35 with different screening modality such as
MRI or ultrasonography would be more appropriate for younger women with
dense breasts. There as an urgent need for more efforts from stakeholders to
develop a national cancer registry with a more comprehensive and full database
representing all UAE for future comparison with other countries in the region.
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This study also recommends that breast awareness education be integrated into
already existing health education programs. In addition, doctors should endeavor
to educate women on "breast awareness" during regular physician office visits for
other health matters. Establishing and organized outreach programs embedded in
the community could be very effective through community educators in which
members from different communities in the UAE will be trained as educators to
conduct regular activities to raise awareness within their communities. Healthcare
providers including physicians, nurses and radiographers need to be offered
regular training and awareness workshops which includes culture sensitivity
awareness as most healthcare professionals in the UAE are from different cultural
and ethnic background.
It is important to encourage health professionals at primary healthcare
centers (PHC) to increase rates of clinical breast examination (CBE) and
mammogram referrals. Enhancing collaboration of different care givers by
encouraging proactive and regular reporting of screening data from all providers
in order to monitor screening rates, with regular feedback to providers is also
advisable. Using survivors and religious leaders as speakers in awareness
activities could increase the response to breast cancer screening initiatives
especially when the response rate is relatively low. Breast cancer awareness
campaigns need to target younger women as participants in the survey claimed
that screening practices are for older women. These campaigns may be having the
undesirable effect of giving younger women the perception that they cannot be
affected. It is recommended that a health promotion campaign be developed to
educate young women about what it is recommended they should be doing and
their risks. This study also recommends that women’s health education should
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occur at an earlier stage in young women’s lives. The suggestion of making it
compulsory for pre-secondary school girls to learn health information and regular
screening for different diseases including breast cancer, cervical cancer and
osteoporosis at school or through appropriately targeted information should also
be considered.
Despite the fact that breast cancer is the leading cancer in the UAE and the
large role culture and psychosocial beliefs play in the health matters of Arab
women, few support services exist in the UAE (Taher et al., 2008). Mainly breast
cancer support is provided through small support groups that women attend. Small
numbers attend these meetings and Emirati women are usually absent. There is no
available psycho-oncologist for support. Breast cancer support services provide
comfort and support to women diagnosed with cancer and their families. Support
services should be provided in different ways, programs be offered to help deal
with the stress of treatments, give information to help make good decisions about
health care, and provide peer support so that women know they are not alone.
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APPENDICES

DISCUSSION GUIDE
Introduction (5 min)
Introduce yourself as a field researcher; explain that as a researcher you are
genuinely interested in knowing the main reasons on why some patients do not
come at an earlier stage to hospital for diagnosis and treatment. We would like to
improve services and their honest opinion would help us a lot. There could be
many reasons and many could be personal. This interview aims to discover the
actual feelings and issues that the patient experience. This discussion will take one
to two hours and would be grateful to switch off all hand phones and lock the door
for no interruptions.
Please fill up the forms given.
Stress that:Interested in personal views and opinions
No right or wrong answer
Explain that audio taping is necessary to do the research analysis and
documentation
Take verbal consent for the interview and the audio taping from the participant
Any questions before we start?

1. Can you tell me what breast cancer means to you?

2. Can you describe your experience on how you discovered your initial
symptom of breast cancer i.e breast lump, pain etc.?
3.

When did you first feel/think that something might be wrong with your
health?

4. What was your initial reaction?
5. What did you do upon discovering that symptom? How long did you take
before seeing a doctor?
6. Why did you take a long time?
7. Who did you confide in when you first discovered your breast cancer
symptom?
8. Why did you confide in this particular person?
9. Have you at any point consulted traditional/ alternative/ religious healer?
10. Can you describe what you went through to arrive at the diagnosis?
11. Probe about clinic visits, biopsy.
12. How was the diagnosis communicated to you?
13. What was your reaction(s) when the doctor told you the diagnosis?
14. How did your life change after the diagnosis (at work and socially)?
15. How did it affect your marital (communication, sexual) relationship, work
and social life?
16. Please elaborate and tell us all the different types of treatment that you
have had so far for breast cancer (modern medicine, alternative medicine
and other types of treatment)?
17. Did they work for you and why is that so?
18. How did you make the decision to have whichever treatment first?
19. Who and what helped you make that decision?
20. Looking back what could have made you make a better decision.
21. As time went by, how did the cancer progress?
22. How did you cope at home, at work and when socializing?

23. Did you face any problems (include emotions; ability to work, financial
(was treatment expensive?)
24. And social relationships)?
25. What are the factors that prevent women from coming early to the hospital
or refuse hospital treatment? There is no right or wrong answer. Most
people might not really know why, but it is okay to share your thoughts.
We would really like your honest opinion on this issue.
26. What are your needs in terms of the health care system (delivery of
services eg. clinic, doctors, nurses, information etc), financial support,
social support and family support?
27. Were the needs met?
28. How these needs can be met?
29. What would you do differently if you knew what you know now?
30. What would you recommend to other women?
31. What would make you have hospital treatment earlier?
32. Probe for financial support, psychological support, social support, more
information and health care delivery.
33. Are there any regrets or disappointment for what you have been through?
34. Did anyone in the family have this disease? In the community? Is this an
openly talked about subject?
35. Do you think by talking about ‘cancer’, this can bring bad luck to you
or/and your family?
36. What education was given to you in regard to your other breast health and
screening?

37. In case I have missed out anything, is there anything else that you would
like to share with me regarding your illness?

Thank you for your time.

Appendix 4: Interviews discussion guide

